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ABSTRACT
The main focus of the research is to understand the complex phenomena of cell
transduction pathways and cell biology in a single cell. Mathematical modeling and ex-
perimental evaluation are widely used approaches for this kind of research. Firstly, A
multiscale framework for protein-protein interaction has been established using Brownian
dynamics algorithm. Sit specific feature, steric collision, diffusion, co-localization and
complex formation with time and space has been included in this spatial modeling frame-
work. By implementation of the time adaptive feature in this framework, the computation
time reduces in an order of magnitude compared with traditional modeling framework.
This multiscale Brownian framework has been used for the investigation FcεRI aggregation
which is an important signaling pathway for immune cells. Using the spatial modeling
framework, FcεRI aggregation in the presence of trivalent antigen showed consistent re-
sults with current experimental studies. Secondly, the rule-based modeling approach is
an excellent way of performing large biochemical network modeling for a single cell as it
considers the site-specific features. However, the major difficulty of rule-based modeling
approach is combinatorial complexity. In this study, model restructuring approaches have
been applied to overcome this problem for cell signaling pathway modeling. These mecha-
nistic modeling approaches are very effective to model large network of signaling pathways
together without compromising the accuracy. Finally, Cell size dependent cellular uptake
study carried out using confocal microscopy and flow cytometer. To understand the particle
uptake behavior with time and steady state condition, reaction-diffusion and kinetics model
has been developed in these work. After a detailed analysis of experimental data and mod-
els, it showed that total particle uptake is increasing with cell size, however, particle flux is
reducing in larger cells.
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1. INTRODUCTION
Over the years, mathematical modeling is playing a vital role in cell and molecular
biology as it is handling the rapidly growing information on cell signaling networks. The
concept of modeling in complex circuitry network is not only limited to the theoretical work
but also facilitates to understand the complex phenomena of cell biology and well defined
experimental design. In the overwhelming complex biological process, mathematical mod-
eling provides insight explanation of the process. These hypotheses can be verified by the
experiments and redefined the model to calculate appropriate parameter values.
1.1. MODELING OF CELL SIGNALING SYSTEM
Modeling of cell signaling networks has emerged as a central scientific research tool
as cell proliferation, differentiation, survival, embryogenesis, metabolism, and apoptosis
are depending on cell signaling pathways (1; 2; 3). Deregulation of cell signaling networks
can cause various malignant diseases such as life-threatening cancers, diabetics, and inflam-
matory syndromes (4; 5; 6). A complex cell signaling pathways have been demonstrated in
Fig. 1.1. Generally, cell signaling networks initiate through receptor activation and aggre-
gation depending receptor types (7; 8; 9). Usually, receptors are transmembrane proteins
which can bind to signaling proteins outside the cell and as a result, intracellular signaling
pathways are activated. Hundreds of receptors are available in a single cell depending on
cell type and the population of the specific receptor also vary on cell type. When a receptor
binds to signaling proteins (ligand), it undertakes a conformational modification that gener-
ates a system of biochemical reactions inside the cell. These biochemical reactions are often
2Figure 1.1. Illustration of complex cell signalling pathways. Figure adapted from Li,
Zhizhong, et al(6).
defined by a system of differential equations which are usually nonlinear (10). Computa-
tional modeling of the cell signaling networks will help us to understand mechanistic insight
of the complex biological systems(10) and can further be tested by experiment. However,
there are several obstacles to model the cell signaling system. Spatial modeling, unavail-
ability of quantitative kinetic data and combinatorial complexity are the major challenges
for mechanistic modeling (10; 11; 12). In another project, I have done an extensive study
on cell size-dependent particle uptake in a mammalian cell. Endocytosis and exocytosis
are important the pathways for particle uptake in a single cell. Besides experimental data, a
mechanistic model is developed to understand the basic mechanism of particle uptake at the
3cellular level. These models describe diffusion and bio-molecular reaction in a single cell.
However, it is quite impossible to include other factors such cell type-specific quantitative
information, and incorporation in our kinetic model as the addition of all these factors will
need more parameter estimation and uncertainty in model prediction. The focus of the study
to understand the effect of cell size and endocytic property that may govern the particle
uptake in a cell.
In this dissertation, I will present my published and unpublished work to overcome
these challenges through appropriate mathematical modeling, restructuration approaches,
and standard experimentation techniques.
1.1.1. MultiscaleModeling for Protein-Protein Interaction. Amultiscale frame-
work has emerged for spatiotemporal modeling of protein-protein interaction. Multivalent
protein-protein interaction is a central theme of cell signaling and gene transcription network
systems. Present modeling and simulation methods are inadequate to capture the spatiotem-
poral complexities of a multivalent system. Multivalent cellular protein molecules repre-
sent site-specific features which includes binding domains and phosphorylation motifs (13).
These features at the submolecular scale play critical roles in their mutual recognition and
binding. A variety of spatiotemporal phenomena at distinct time and spatial resolutions
influence the multivalent site-specific binding and assembly of protein molecules (14). The
steric hindrance arising from the geometric orientation of the domains and motifs may have
important effects on their mutual recognition (15; 16). Moreover, the transport barriers in
the cellular compartments may also determine their interaction and assembly (17). On the
other hand, space and time involved in protein diffusion, colocalization, and formation of
complexes could be relatively large. Bridging these processes at various time and spatial
scales in a model is computationally challenging.
Here, we showed an agent-based framework integrated with a multiscale Brown-
ian Dynamics simulation algorithm. The framework employs spatial graphs to describe
multivalent molecules and complexes with their site-specific details. By implementing
4a time-adaptive feature, the Brownian Dynamics algorithm enables efficient computation
while capturing the site-specific interactions of the diffusing species at the sub-nanometer
scale. We demonstrate these capabilities by developing models of multivalent ligand-
receptor assembly in the plasma membrane of cells. Using the models, we provide an
analysis of the computational performance and prediction accuracy of the algorithm. We
demonstrate that the algorithm can accelerate computation by orders of magnitudes in both
concentrated and dilute region. We also show that the algorithm enables robust model pre-
dictions against a wide range of selection of time steps. The method could be particularly
useful in interrogating the spatiotemporal phenomena arising from the steric effects and
transport of biomolecules in the heterogeneous cellular compartments. Further extension of
the algorithm with proper parallelization may enable large-scale spatiotemporal modeling
and simulation biochemical network pathways.
1.1.2. Self-Limiting FcεRICrosslinking byMultivalent Antigens. We have pre-
sented the application of our agent-based framework integrated with a multiscale Brow-
nian Dynamics simulation algorithm for trivalent ligand bivalent receptor (TLBR) sys-
tem. Receptor aggregation by multivalent antigens is an essential early step for immune
cell signaling. Mast cells and basophils initiate a biochemical network through trivalent
antigen-mediated FcεRI receptor aggregation (7; 17; 18). The structure of FcεRI with
crosslinking multivalent antigen is well defined and reveals comprehensive information
about functional receptor aggregation through experiment (7; 17; 18). Many multivalent
ligands are bound to the cell surface receptors to form receptor aggregation that stimulates
cellular responses (12; 18). In this work, we have studied a couple of mechanistic inquiries
related to receptor aggregation by using mast cell FcRI receptor which has a high affinity
towards IgE as a model system. In recent years, several mathematical modeling and exper-
imental studies have demonstrated for ligand-mediated IgE receptors aggregation (FcεRI)
of the mast or basophils cells in the plasma membrane. However, the mechanisms of FcεRI
aggregation is not fully understood by the researchers. In recent experimental work, Small
5and finite size clusters of FcεRI aggregates formed by stimulating with a multivalent ligand.
However, the mathematical model analysis showed the super-aggregates of FcεRI receptor
when the bivalent FcεRI receptors bind with a trivalent antigen ligand. The formation of
large aggregates has a potential effect to give rise the hyperactive responses in human cells.
To understand the FcεRI receptors aggregation phenomena, our established multiscale spa-
tiotemporal framework has been used. This spatial framework captures the site-specific
feature of a molecule and complex, membrane diffusion, steric collisions, and site-specific
interactions molecules with time. On another hand, most of the current models are based on
nonspatial simulation techniques that are not useful it is implicitly capturing the above spa-
tial model features. In this study, a detailed mathematical modeling analysis was performed
using FcεRI aggregation data from a published experimental article (17). The model anal-
ysis showed that the species has sharp decay in mobility at the plasma membrane when
the bivalent ligand stimulates with a trivalent antigen. This model prediction is consistent
with the experimental data analysis. Due to sharp decay of the species mobility, FcεRI
aggregation becomes self-limiting. The analysis of FcεRI shows the potential mechanism
to suppress the hyperactivation of immune cells in the presence of multivalent antigens.
1.1.3. Model Restructuring Approaches. Understanding the complex phenom-
ena underlying biochemical and biological systems requires large-scale mechanistic models.
Over the years, new modeling approaches and algorithms have been developed to account
for the greater degree of biological complexity in a model. The rule-based modeling (RBM)
approach is a specialized technique to develop models considering site-specific multivalent
interaction and transformation of signaling protein molecules (19; 20). Theoretically, the
RBM models can describe a biochemical network system with arbitrary levels of complex-
ity. However, the limiting factor is often the combinatorial complexity associated with
these models. The model restructuration approaches introduced in this work will create
an unprecedented opportunity to capture biological complexity in the RBM models. In
this work, we present a new method for the systematic reduction of mechanistic models
6developed using the RBM approach. The model restructuration approaches are particularly
useful for cell signaling network models where site-specific binding and transformation
of multivalent molecules give rise to a large number of species and reactions. By ap-
plying these techniques, we systematically reduced this model into an equivalent model
with a much smaller network. The restructured model was identical to the natural model
without compromising the accuracy. We also demonstrate the general applicability of the
approach by creating detailed mechanistic models of the receptor tyrosine kinase (RTK)
systems(1). We identify five distinct mechanisms whereby the RTKs become activated in
the cell membrane. For each mechanism, we develop a rule-based model by incorporating
comprehensive details of ligand-receptor binding, receptor phosphorylation, and recruit-
ment of downstream signaling proteins. By applying our approach, we restructure these
models and provide analysis on their network dimension, computational performance, and
accuracy of prediction.
1.1.4. Cell Size and Nanoparticle Uptake. Over the decades, nanoparticle-based
cancer therapy is an evolving technology. However, a major challenge for this field is the
poor understanding of nanoparticle transport and interaction in biological tissues. In past
few years, significant efforts have been directed to investigating cellular interaction and
uptake of nanoparticles (21; 22). This has led to remarkable progress in elucidating the
effects of various nanoparticle properties on their mean (cell population-average) uptake
behavior (23; 24; 25). In contrast, less attention has been paid to understand how a
cell’s own physical attributes may determine nanoparticle uptake behavior at the single-cell
level. Therefore, the parameters and conditions defining the characteristics of single-cell
nanoparticle uptake remain poorly understood. In this work, using mathematical modeling
and quantitative experimental analysis, we want to investigate the effect of cell size and
endocytic components (transporters) in cellular level particle uptake. The cell size plays an
important role in particle uptake as particle uptake depends on cell surface area or cell mass
according to the traditional concept. However, the transporter expression in a cell can be a
7critical factors for particle uptake. Particle uptake also depends on extra cellular diffusion,
particle trafficking , internalization process and cell type. However, In this study, the focus
is to explore how the cell size and transporter density affect the cellular uptake behavior in a
single cell. Flow cytometry, confocalmicroscopy, andfluorescencemicroscopy experiments
have been performed to find out the correlation between cell size and nanoparticle uptake in
MDA-MB 231 cells. The effect of transporter density in nanoparticle uptake is connected
with cell size. Reaction-diffusion model has been developed to correlate the cell size and
particle uptakewhere the kinetic model describes the transporter expression and their uptake
behaviour in a single cell. The models accurately describe the single-cell particle uptake
data and identifies key parameter values defining the uptake characteristics of MDA-MB
231 cells.
1.2. DISSERTATION ORGANIZATION
The dissertation consists of the following sections:
•Section: Background of cell signalling modeling, motivation along with
brief literature review and experimental procedures.
•Paper I: Multiscale Algorithm for Spatiotemporal Modeling of Multivalent
Protein-Protein Interaction.
•Paper II: Spatiotemporal Model Reveals Self-limiting FcεRI Crosslinking
by Multivalent Antigens.
•Paper III: Cellular Heterogeneity in Endocytic Nanoparticle Uptake: Dis-
secting the Origin Using Quantitative Experiments and Modeling.
•Paper IV: Quantitative analysis of the correlation between cell size and cel-
lular uptake of particles.
8•Paper V: Systematic Reduction of Rule-Based Model Dimension: Applica-
tion to Receptor Tyrosine Kinase Modeling.
•Section: Conclusions and Future Works.
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This paper introduces a multiscale framework for spatiotemporal modeling of
protein-protein interaction. Cellular protein molecules represent multivalent species that
contain modular features, such as binding domains and phosphorylation motifs. The bind-
ing and transformations of these features occur at a small time and spatial scale. On the
other hand, space and time involved in protein diffusion, colocalization, and formation of
complexes could be relatively large. Here, we present an agent-based framework integrated
with a multiscale Brownian Dynamics simulation algorithm. The framework employs spa-
tial graphs to describe multivalent molecules and complexes with their site-specific details.
By implementing a time-adaptive feature, the Brownian Dynamics algorithm enables effi-
cient computation while capturing the site-specific interactions of the diffusing species at
the sub-nanometer scale. We demonstrate these capabilities by modeling two multivalent
molecules, one representing a ligand and the other a receptor, in a two-dimensional plane
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(cell membrane). Using the model, we show that the algorithm can accelerate computation
by orders of magnitudes in both concentrated and dilute regimes. We also show that the
algorithm enables robust model predictions against a wide range of selection of time step
sizes.
Keywords: Multiscale modeling, Brownian Dynamics, Cell Signaling, Diffusion, Ligand-
Receptor
1. INTRODUCTION
Akey challenge to spatiotemporal modeling ofmultivalent species is to deal themul-
tiscale nature of the problem (1). Multivalent protein-protein interaction is a central theme
of cell signaling and gene transcription. Cellular protein molecules represent multivalent
species with modular features, such as binding domains and phosphorylation motifs (3).
These features at the submolecular scale play critical roles in their mutual recognition and
binding. The molecular-scale domains and motifs of the cellular proteins mediate interac-
tions at very small spatial and temporal scales. In contrast, the protein molecules are subject
to long-range diffusion in and across the cellular compartments (16).
Several models have been developed in the past to study multivalent antigen-
mediated IgE receptor clustering in the plasma membrane of mast cells (6; 8; 11; 12).
However, these models were either equation-based deterministic models or developed using
a non-spatial Kinetic Monte Carlo approach called network-free simulation (15; 17; 18).
The explicit geometric features of molecules and complexes were missing in these models.
In this paper, we introduce a multiscale Brownian Dynamics (BD) simulation al-
gorithm that enables accelerated computation while capturing the sub-nanometer scale
site-specific interactions of the molecules and their complexes. We develop a model of
a trivalent ligand and a trivalent receptor molecule and their diffusion, rotation, and site-
specific binding in the plasma membrane of a cell. The multivalent molecules and their
site-specific features are described by spatial graphs. The mobile ligand-receptor graphs
11
form larger graphs (multimolecular complexes) that evolve dynamically during the course
of a simulation. The lateral and rotational motion of the molecules and evolving com-
plexes are simulated using the BD algorithm. Using the model, we provide analysis on the
computational performance and accuracy of our algorithm. We show that the algorithm
speeds up computation by orders of magnitude without compromising the accuracy in both
concentrated and dilute regimes. Moreover, we show that the time-adaptive feature enables
robust predictions against a wide range of selection of time steps.
2. METHODS
Below, we first provide details of the model. We then explain the multiscale
Brownian Dynamics algorithm.
2.1. MODEL
The model is a reaction-diffusion model of multivalent ligand-receptor interaction
in the cell plasma membrane. The model is developed using the agent-based approach (5).
More details are provided below.
2.1.1. Cell Membrane, Molecules, and Complexes. We consider a 1 µm2 two-
dimensional plane, which represents a small part of the cell membrane (∼ 0.3% of the
surface area of a spherical cell of 5 µm radius). We consider a trivalent ligand and a
trivalent receptor molecule that we describe by spatial graphs (7) (Figure 1). A spatial
graph is a collection of small circles (nodes). The spatial organization of these nodes
creates a coarse-grained structure of a molecule. When two or more such molecule graphs
combine in a prescribed manner, they form a complex graph. Each ligand or receptor
molecule contains three equally-spaced binding arms. In each binding arm, one node is
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designated as the reaction center (Figure 1). The reaction centers serve as the mutual
recognition sites of the ligand and receptor molecules. In a complex, the molecules remain
linked via these reaction centers (Figure 1C).
2.1.2. Motion of Molecules and Complexes. We consider both lateral diffusion
(translation) and rotation of the molecule and complex graphs. The diffusion and rotation
rates are determined by their effective size. To define the effective size for a graph, we
consider a circle that completely contains the corresponding structure (Figure 2A). The
circle is centered at the center of mass of the structure. The center of mass is determined
by the mass of individual nodes and their spatial locations. We consider identical mass
for all nodes because they have an identical size in the model (Table 1). The radius of the
circle extends from this center to the farthest node. We define the circle area as the effective
region (A), and its radius as the effective size (a). For a molecule graph, a remains fixed
over time. However, for a complex graph, a is designated as a(t) because it evolves with
the complex size and geometry over time.
For a ligand or receptor molecule, we predefine their diffusion constants Dm (Ta-
ble 1). For a complex graph, diffusion evolves based on the following rule: D(t)/Dm =
am/a(t), where am and a(t) represent the effective size of a molecule and complex, re-
spectively. This rule obeys the Stokes-Einstein formula according to which the diffusion
Figure 1. Illustration of the species (molecules and their complexes). (A) A trivalent ligand
molecule. (B) A trivalent receptor molecule. (C) A ligand-receptor complex.
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Figure 2. Illustration of the BD simulation algorithm. (A) A complex and its effective
region (gray circle) and effective size (a). (B) A species (gray region at the center) and its
search domain (blue region). The species has four collision partners (other gray regions
with the search domain). (C) The center-to-center distance between a species (Agent 4) and
its collision partners (Agents 1, 2, 3, and 5). (D) Overlap between the effective regions of
agent 4 and 5. Such overlap is permitted ensuring the graphs within the gray circles never
collide. When any such overlap happens in the entire system, the algorithm makes sure all
species are advanced by less than 1 nm in each step.
coefficient is inversely related to particle radius. In a similar way, for a ligand or receptor
molecule, we predefine their rotation speed (ωm) (Table 1). For a complex, the rotation
speed ω(t) obeys the following rule: ω(t)/ωm = am/a(t).
During the course of a simulation, we translate or rotate each graph as a rigid body.
In each time step ∆t, we first advance a graph by a distance
√
4D(t)∆t ®e, where ®e is a unit
vector in a random direction. We then rotate the graph around its center of mass by an angle
ω(t)∆t. We randomly select the rotation direction clockwise or anti-clockwise.
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2.2. TIME-ADAPTIVE BROWNIAN DYNAMICS ALGORITHM
Themultiscale simulation algorithm is illustrated in Figure 2. The algorithm ensures
collision-free motion of the structures defined by the molecule and complex graphs, as
discussed below.
2.2.1. Calculation of Adaptive Step Size. For each molecule or complex agent,
the algorithm assigns a local search domain of radius S. In Figure 2B, the two concentric
gray and blue circles illustrate a species agent and its search domain, respectively. The gray
circle at the center represents the effective region of the species. The blue circle represents
the search domain whose radius (S) is a tunable parameter.
In the algorithm, an upper bound lmax limits the particle jumps in a single step. lmax
is the maximum distance any agent can travel over a single time step ∆t. We set lmax < S.
Thus, an agent can find all its potential (current) collision partners within its search domain.
The agent in Figure 2B has four partners (other gray circles inside the blue circle).
In each BD step, the algorithm evaluates dk, j , the center-to-center distance between
each agent k and each of its collision partners j ∈ {1 · · · ,mk(t)} (Figure 2C,D). Here, the
center of an agent implies the center of mass of the graph represented by the agent. The
algorithm then computes the collision distance, dck, j = dk, j − (ak + a j), where ak and a j
are the effective size of the graphs corresponding to agent k and j, respectively. Next, for
the entire system, it identifies the smallest dck, j : d
c
min = min{dck, j}, where k ∈ {1, · · · , n(t)}
(assuming the system has n(t) species at time t), and j ∈ {1, · · · ,mk(t)}. This distance,
dcmin, is then used to determine the time step size ∆t, as discussed next.
If dcmin > 0, all the grey circles representing the effective regions of the agents
(graphs) in the system are at non-overlapping positions. Under this condition, the algorithm
first evaluates the shortest possible time∆tc thatmight lead to an overlap or collision between




D j(t))2}, where k ∈ {1, · · · , n(t)} and
j ∈ {1, · · · ,mk(t)}. Dk(t) and D j(t) are the instantaneous diffusion coefficients of the
corresponding agents. The algorithm then compares ∆tc with a prescribed lower-bound on
15
the time step size, ∆tmin. If∆tc > ∆tmin, the algorithm sets∆t = ∆tc, and advances all agents
by
√
4Dk(t)∆tc. This distance in a single step could represent a wide range of selections
below the upper limit lmax , which has a default value of 100 nm in our simulations. However,
if ∆tc ≤ ∆tmin, the algorithm sets ∆t = ∆tmin, and advances all agents by
√
4Dk(t)∆tmin.
We consider ∆tmin = 10−5 seconds. At this time resolution, all graphs in our model are
expected to advance by less than 1 nm in a single step.
If dcmin ≤ 0, at least one pair of circles in the system is in overlapping positions
(Figure 2D). This implies that at least one pair of graphs (contained by those overlapping
circles) are in close proximity to collide or mediate site-specific binding. Under such a
condition, a high-resolution step is preferred to account for the steric collision or site-
specific binding. the algorithm identifies the time step ∆t based on the following rule:
∆t = max{min{l2min/4Dk(t)},∆tmin} for k ∈ {1, · · · , n(t)}. Here, lmin is a defined small
length (a tunable parameter in the algorithm). We set lmin = 1 nm. This ensures all graphs
are advanced by less than 1 nm in each step whenever there is an overlap of the effective
regions.
2.2.2. Collision Rejection and Site-Specific Binding. The algorithm allows over-
lap of two circles (effective graph regions) while ensuring that the graphs within those
circles are advanced in a collision-free manner. If a move results in a collision between
two graphs, the move is rejected for the two graphs only. We consider a thin reaction layer,
lr = 0.1 nm, around each reaction center. When the reaction center of a ligand molecule
and that of a receptor molecule fall within lr , an implicit bond is assumed that holds the
molecules together. In this work, we consider high-affinity ligand-receptor interaction and
assume irreversible bond formation. We prohibit intra-complex binding or ring formation
(11; 12). Only chain and branched structure are allowed.
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2.2.3. Code Implementation. The simulation algorithm and the model were spec-
ified in C++. The C++ code is provided in the Supplementary Information. All simula-
tions were conducted on a dedicated node on AMAZON Elastic Compute Cloud (EC2):
c3.4xlarge (16vCPU, 30 GiB, 2 × 160).
3. RESULTS
3.1. SIMULATION OF MULTIVALENT LIGAND-RECEPTOR SYSTEMS
In Figure 3A and B, we show snapshots from our simulations. At time zero, the
molecules were initiated at random non-overlapping positions in the membrane domain,
and snapshots were taken after 500 seconds of simulation.
Figure 3C shows the time evolution of receptor clustering. Themean cluster size rep-
resents the average of the number of receptors incorporated in the ligand-receptor complexes
at the indicated time points. Initially, all receptors were available as isolated molecules,
and hence the mean cluster size was 1 at time zero. As time progressed, larger (and fewer)
clusters populated in the system. Figure 3D shows how the computation time (CPU time)
evolved as the simulation progressed. Most of the computation was spent in the first few sec-
onds because the system was in a concentrated regime (species were either single molecules
or small complexes). As the simulation progressed, larger (and fewer) species formed and
the system approached a dilute regime. In the dilute regime, the adaptive algorithm took
larger steps, thus accelerating computation.
Figure 4 shows some representative snapshots from simulations that involved differ-
ent othermultivalent ligand-receptor combinations. Amovie file showing the time-evolution
of a trivalent ligand-trivalent receptor system is included in the Supplementary Information.
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3.2. GAIN IN COMPUTATION SPEED
We evaluated the computational performance of our algorithm against a naive im-
plementation of the model (Figure 5). In the naive implementation, the time step ∆t was
held fixed and the search domain (S) was infinite. The fixed ∆t was chosen so that a single
ligand or receptor molecule in each step could advance only by 1 nm, which is the smallest
step size for the adaptive algorithm. The trivalent ligand-receptor system was simulated
using the naive and adaptive approach for a dilute and a concentrated regime (Figure 5A
and B, respectively), and corresponding computation (CPU) times were compared.
Figure 3. Simulation of a trivalent ligand-trivalent receptor system. The ligand and receptor
molecules are indicated in green and red, respectively. (A) A branched complex structure
formed in the simulation. (B) A small part of the structure in Panel A. (C) Time evolution
of receptor aggregation. (D) Computation (CPU) time versus simulation time.
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Figure 4. Simulation snapshots of multivalent ligand (green)-receptor (red) systems. In all
cases the receptor is trivalent while the ligand is bivalent (A), trivalent (B), pentavalent (C),
and decavalent (D).
The figure shows a dramatic reduction in computation time in the adaptive algorithm.
The difference between the naive and adaptive algorithm is even more pronounced in
the dilute regime, where the naive algorithm spent most of the computation in particle
advancement.
3.3. ROBUSTNESS AND ACCURACY
The results we have discussed so far represents lmax = 100 nm. A larger lmax accel-
erates computation but a smaller lmax is desired for higher spatial and temporal resolution
(accuracy). However, as discussed in Methods, the algorithm requires lmax ≤ S, where S is
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Table 1. Default parameter values of the model.
Parameter Comment
L = 1, 000 nm Membrane length
W = 1, 000 nm Membrane width
nL = 100 Ligand copy number.
nR = 100 Receptor copy number
nsiteL = 3 Number of binding arms in a ligand
nsiteR = 3 Number of binding arms in a receptor
neL = 5 Number of nodes per ligand arm
neR = 5 Number of nodes per receptor arm
re = 0.5 nm Radius of each node
Dm = 10−10 cm2/s Diffusion coefficient of a ligand
or receptor molecule
ωm = 10 radian/s Rotation speed of a ligand
or receptor molecule.
lr = 0.1 nm Reaction layer thickness.
S = 100 nm Radius of the local search domain.
lmax = 100 nm Upper limit on particle jump size.
lmin = 1 nm Limit on jump size when effective
regions overlap.
∆tmin = 10−5 s Lower bound on time step size.
the local search radius associated with each species in the system. A larger S may facilitate
computation by permitting a larger lmax but involves more computation in checking possible
collision among the species.
We investigated three different combinations of lmax and S (Figure 6). The black
lines in both panels of Figure 6 represents the case where S = 100 nm and lmax = 1
nm (S : lmax = 100:1). We expected this combination to yield more accurate simulations
because it enforced a high spatiotemporal resolution by constraining all particle jumps
below 1 nm. The green lines represent the case where we considered the default scenario
(Table 1): S = 100 nm and lmax = 100 nm (S : lmax = 100:100). The red lines represent
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Figure 5. Computational speed gain in the time-adaptive algorithm. All simulations
involved 100 trivalent receptor and 100 trivalent ligandmolecules. (A)Concentrated regime:
1, 000 nm × 1, 000 nm membrane domain. (B) Dilute regime: 10, 000nm × 10, 000nm
membrane domain.
the case where we set S = 10 nm, and lmax = 10 nm (S : lmax = 10:10). We compared
the prediction accuracy (Figure 6A) and computational efficiency (Figure 6B) among these
three cases.
Figure 6A shows the predicted mean receptor cluster size as a function of time under
the above three conditions. Except for the stochastic variations, the predictions are closely
similar in all three cases, indicating the robust behavior of the time adaptive feature. Despite
the distinct upper bounds (lmax), the algorithm adapted the step sizes as necessary to capture
the site-specific interactions with similar accuracies.
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Figure 6. Sensitivity and computational performance under different combinations of S and
lmax . Three different combinations were chosen and compared. The lines in different color
correspond to different ratio of S and lmax: 100 nm:1 nm (black), 100 nm:100 nm (green),
and 10 nm:10 nm (red). Each line is the average of 30 realizations. The shaded regions
represent corresponding standard deviations.
Figure 6B compares computation time among the three conditions above. First, it is
interesting to note that the 100:1 case took only ∼ 3,500 CPU seconds despite the adaptive
feature was compromised with lmax = 1 nm. Corresponding naive simulation, where we
also restricted the step size below 1 nm, took ∼ 300, 000 seconds (Figure 6A). Therefore,
the accelerated computation in the 100:1 case is not due to the adaptive feature. Rather
it is due to the local search feature of the algorithm. The 100:1 case involves search over
a domain of 100 nm radius, whereas the naive implementation involves a search over the
entire membrane domain to avoid species collision.
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The two other cases (100:100 and 10:10) revealed modest improvements in compu-
tation speed compared to the 100:1 case. Nevertheless, these two cases plateaued rapidly
as the system approached from the concentrated to dilute regime. This indicates that the
adaptive feature could be of greater advantage in the dilute regimes. On the other hand, the
local search feature alone can improve computation speed significantly in a concentrated
regime.
4. DISCUSSION
In this work, we have demonstrated a computationally efficient algorithm for model-
ing reaction-diffusion systems involving multivalent molecules. Here, we limited our focus
to modeling cell-surface ligand-receptor assembly, a key early step of immunoreceptor and
receptor tyrosine kinase (RTK) signaling (4; 13; 14). The approach and analysis could
be adapted for modeling and simulation of more complex multivalent species or particle
interactions in molecular biology or other fields.
Among the existing spatiotemporal modeling tools, SRSim (7) provides a unique
capability for spatiotemporal modeling of macromolecular assembly. SRSim also employs
spatial graphs to represent protein molecules and complexes. However, SRSim simulations
more comparable could be expensive for the time and spatial scales of signaling protein
interactions. MCell (2) is a spatiotemporal modeling tool with the special capability to
consider complex geometries for cellular compartments. However, MCell treats reaction
species as featureless points (9). Therefore, it has a limited ability to incorporate site-specific
attributes of the biomolecules. VirtualCell (10) is another spatiotemporal modeling tool.
However, it is primarily limited to partial differential equation (PDE)-based deterministic
modeling. It might be useful to extend our multiscale approach to incorporate some of the
unique features of the above tools. In particular, our algorithm might be coupled to features
creating complex geometries for the reaction compartments, as implemented in MCell.
23
In this work, we have limited the scope to modeling protein-protein interactions
in the plasma membrane, which is often treated as a two-dimensional space. However, a
three-dimensional extension of the approach might enable modeling the cytoplasmic and
extracellular compartments. We expect that the computational benefits of our algorithm
will be significant in a three-dimensional space where simulation of particle advancement
could be more expensive than that in a two-dimensional system.
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Aggregation of cell-surface receptor proteins by multivalent antigens is an essential
early step for immune cell signaling. A number of experimental and modeling studies in the
past have investigated multivalent ligand-mediated aggregation of IgE receptors (FcεRI) in
the plasma membrane of mast cells. However, understanding of the mechanisms of FcεRI
aggregation remains incomplete. Experimental reports indicate that FcεRI forms relatively
small andfinite-sized clusterswhen stimulated by amultivalent ligand. In contrast, modeling
studies have shown that receptor crosslinking by a trivalent ligand may lead to the formation
of large receptor superaggregates that may potentially give rise to hyperactive cellular
responses. In this work, we have developed a Brownian Dynamics-based spatiotemporal
model to analyze FcεRI aggregation by a trivalent antigen. Unlike the existing models,
which implemented nonspatial simulation approaches, our model explicitly accounts for the
coarse-grained site-specific features of the multivalent species (molecules and complexes).
The model incorporates membrane diffusion, steric collisions, and sub-nanometer-scale
site-specific interaction of the time-evolving species of arbitrary structures. Using the
model, we investigated temporal evolution of the species and their diffusivities. Consistent
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with a recent experimental report, our model predicted sharp decay in species mobility in
the plasma membrane in response receptor crosslinking by a multivalent antigen. We show
that, due to such decay in the species mobility, post-stimulation receptor aggregation may
become self-limiting. Our analysis reveals a potential regulatory mechanism suppressing
hyperactivation of immune cells in response to multivalent antigens.
Keywords: Multivalent,Antigens,superaggregate,Browian dynamics,Coarse-grain
1. INTRODUCTION
Crosslinking of cell-surface receptor proteins by antigens is an essential early step
for the activation of all immunoreceptor signaling pathways. In the past, both experimental
andmodeling studies investigatedmultivalent ligand-mediated crosslinking of IgE receptors
(FcεRI) in the plasma membrane of basophil or mast cells(1; 2; 3; 4; 5; 6; 7; 8). Synthetic
multivalent ligands have been used to understand the correlation betweenmembrane cluster-
ing of FcRI and cellular histamine release or degranulation (8; 9; 10; 11; 12; 13). However,
the mechanistic understanding of multivalent ligand-FcεRI assembly in the cell membrane
remains incomplete.
A number of experimental studies have found that stimulation of cells with a syn-
thetic multivalent ligand forms finite-sized FcRI clusters in the plasma membrane(8; 14).
This observation contradicts with model-based analysis(3; 7). An early theoretical model
by Goldstein and Perelson(3) predicted that stimulation of a bivalent FcεRI with a trivalent
ligand may lead to a condition where all the receptors can be incorporated into a single
large complex (superaggregate or gel). They postulated that such superaggregate formation
might enable a cell to be hyperresponsive against infection. Recently, using a stochastic
model, Monine et al.(7) also showed similar phenomenon in FcεRI aggregation. Lately,
Mahajan et al. (8) reported a model similar to the model of Monine et al.(7). However, this
model imposed a condition on receptor crosslinking to prohibit superaggregate formation.
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A common caveat of these earlier models was that the models were nonspatial
and hence lacked the ability to incorporate the spatiotemporal effects, such as membrane
diffusion, steric collision, and geometry of the dynamically evolving species (ligand and
receptor molecules and their complexes). We were interested in investigating whether
a spatial model could explain the reported behavior of FcεRI aggregation. A recent
experimental study by Shelby et al. (14) indicates that the diffusion of multivalent antigen-
crosslinked receptors falls dramatically upon stimulation of mast cells. The question we
wanted to answer is whether such decrease in the receptor mobility could ultimately dictate
receptor crosslinking and the size distribution of FcεRI aggregates in the plasmamembrane.
To develop a spatial model, we needed a computationally-efficient simulation frame-
work that can efficiently capture the site-specific interactions of the molecules and com-
plexes at reasonably high resolutions. A typical Molecular Dynamics (MD) simulation was
deemed infeasible because of the timescale and spatial domains of our interests. Therefore,
we adopted a Brownian Dynamics (BD)-based approach. To leverage computation, we im-
plemented a time-adaptive feature in the BD simulation algorithm based on our recent work
(15). We integrated the time-adaptive BD algorithm with an agent-based framework, where
we used spatial graphs to define the coarse-grained structures (site-specific features) of the
trivalent ligand and bivalent FcεRI molecules in a two-dimensional plane (cell membrane).
Using the model, we investigated the effects of membrane diffusion on the interac-
tion of dynamically-evolving ligand-receptor complexes. Consistent with (14), our model
indicated that there could be a rapid decay of species diffusion in the membrane upon stim-
ulation by a multivalent antigen. We showed that the dynamics of this decay is correlated to
the level of receptor density in the cell membrane. We compared the predictions of our spa-
tial model with a non-spatial model, which we developed based on the models in (7; 8). The
spatial model predicted finite-sized receptor clusters distributed over a broad range of sizes.
In contrast, the nonspatial model revealed a single superaggregate incorporating approxi-
mately all receptors. We found that when the diffusion constant in the spatial model was
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made time-invariant and species-independent, it also predicted superaggregate formation
like the nonspatial model. These results underscore a limitation of the nonspatial models,
where a bimolecular association rate constant accounts for the ligand-receptor assembly
while ignoring the time-evolving size and geometry of the species. Our analysis indicates
that cell-surface receptor aggregation could be self-limiting due to the growing aggregate
sizes and concurrent reduction in their mobilities. We conclude that such a self-regulatory
mechanism may serve to contain hyperactive cellular responses.
2. MATERIAL AND METHODS
Our spatiotemporal model was based on a trivalent ligand and a bivalent receptor
molecule. The model resembles the trivalent ligand and bivalent FcεRI systems studied in
(8). The model is developed using the agent-based approach combined with a time-adaptive
Brownian Dynamics (BD) simulation algorithm. Below we provide the details of the model
and the BD algorithm.
2.1. SPATIOTEMPORALMODELOFTRIVALENTLIGANDBIVALENTRECEP-
TOR INTERACTION IN THE CELL MEMBRANE
In our model, ligand and receptor molecules are described by agents or software
objects. We consider a two-dimensional rectangular plane to define the plasma membrane,
where the molecules can diffuse and mediate site-specific interactions. Using an approach
similar to (16), we use spatial graphs to describe the ligand and receptormolecules (Figure 1).
A spatial graph is a collection of small circles, which we refer to as subunits. The spatial
orientation of the subunits defines the structure of a molecule and its site-specific features,
such as binding domains or motifs. We define a ligand molecule based on the synthetic
trivalent ligand described in Mahajan et al. (8). The molecule has three identical binding
arms each of which is ∼ 17 Å long. The binding arms are symmetrically spaced, i.e., the
angle between two adjacent arms is 1200. We consider a single subunit of radius 1.5 Å to
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Figure 1. Illustration of spatial graphs. (A) A trivalent molecule. The white unfilled circle
at the center defines the molecule center, and each yellow circle represents a reaction center.
(B) A bivalent receptor molecule. The unfilled circle at the center defines the molecule
center, and each yellow circle represents a reaction center. (C) A ligand-receptor complex.
define the center of the molecule (Figure 1A). We define each binding arm by five adjacent
subunits each of which is also 1.5 Å in radius. Thus, the distance between the molecule
center to the tip of each binding arm is ∼ 16.5 Å. We consider each binding arm to have a
reaction center that can form a bond with a complementary region of a receptor molecule.
In each binding arm, we designate the subunit at the tip as the reaction center (yellow circles
in Figure 1A).
We model the bivalent FcεRI by a graph containing two identical binding arms 1800
apart (Figure 1B). Reports indicate that the approximate FcεRI radius is 46−51 Å (17). We
consider each binding arm to have 5 identical subunits each of which is also 5 Å in radius.
Thus, the length of each binding arm is 50Å . We consider a molecule center separating
these two arms. A single subunit of 5Å radius defines the molecule center. Similar to a
ligand molecule graph, each binding arm contains a reaction center at the tip (yellow circles
in Figure 1B). In the model, when the reaction centers of a ligand and a receptor molecule
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graph come within a close proximity (a predefined short distance that we call reaction
layer), they may form an (implicit) bond. The bond holds the two molecules together
in a complex. Similarly, a complex may form larger complexes through association with
other molecules or complexes via their unoccupied reaction centers. Figure 1C illustrates a
complex containing multiple ligand and receptor molecules.
2.2. TIME-ADAPTIVE BROWNIAN DYNAMICS SIMULATION ALGORITHM
We use a time-adaptive Brownian Dynamics (BD) algorithm to simulate species
diffusion in the two-dimensional membrane. The time adaptive feature is included to
accelerate computation, especially in the dilute regimes. The algorithm is based on our
recent work (15). It selects the time step sizes adaptively to facilitate computation while
capturing the site-specific interactions of the species at the sub-nanometer resolution.
2.2.1. Lateral and Rotational Diffusion of Species. In the BD algorithm, we con-
sider both lateral and rotational diffusion for the spatial graphs representing the species
(molecules and complexes). Because the size and structure of these graphs evolve dy-
namically due to their site-specific assembly and dissociation, their lateral and rotational
diffusivities also change with time. In every BD step, a species graph is translated or rotated
as a rigid body over time step ∆t. We assume that the translation and rotation of a graph
occur with respect to its center of mass. Both types of diffusivities of a graph depend on
its instantaneous size. We determine the center of mass (C) and the size (R) of a graph
as explained next. We consider a weight associated with each subunit of a molecule. The
receptor molecule has a total of 11 subunits, whereas the ligand molecule graph has a total
of 16 subunits. We assign each receptor subunit a mass of 1 (arbitrary unit). Comparing the
volume of a ligand subunit with that of a receptor subunit, we assign each ligand subunit a
mass of 0.027. Because these molecule graphs have symmetric structures, their center of
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Figure 2. Disk representation of molecules and complexes. Each molecule and complex
graph is contained by a hypothetical disk (gray circles). The center of each disk is located
at the center of mass of the corresponding graph. The radius of the disk is the shortest
distance that allows the disk to fully encompass the structure of the graph. The radius of the
disk represents the effective radius of the corresponding species. (A) The center of mass
(C) and effective radius (R) of a ligand molecule, a receptor molecule, and a complex. (B)
Molecule and complex graphs in a two-dimensional plane (cell membrane). The variable
di, j represents the distance between a pair of disks i and j. A negative di, j implies the
overlap between the two disks. Such overlap is permitted as long as the structure defined
by the graphs do not collide or conflict.
mass corresponds to the molecule center (Figure 2A). However, for a multimolecular com-
plex, the center of mass depends on the instantaneous spatial organization of the subunits
(Figure 2A).
We define the size of a graph by its effective radius R. To calculate R, we envision
a hypothetical disk encompassing each species graph (Figure 2A). The center of the disk
is located at the center of mass of the graph. We consider R to be the distance from
the center of mass to the farthest point of the graph. For example, if (x, y) represents
the center of mass of a graph, and (xi, yi) represents the center of any subunit i, then
R = max{(
√
xi − x)2 + (yi − y)2 + ri}, where ri is the radius of subunit i.
We relate the diffusion constant a species to its size by the following expression:
D ∝ 1/Rα. Here, the exponent α is a tunable parameter in the model. Setting α = 0 makes
D a constant (independent of time or species). This condition corresponds to a nonspatial
model, where the single-site ligand-receptor association is governed by a constant rate
32
parameter typical for any bimolecular reaction. At α = 1, D evolves naturally (based on the
Einstein-Stokes equation) with the size of a graph. Finally, at α > 1, the model captures an
arbitrarily large decrease of D of a growing species.
For an isolated receptormolecule, whose size (and hence diffusion) is time-invariant,
we consider a baseline diffusion constant, D0 = 104 nm2/s (18). For any other species,
which includes an isolated ligand molecule, we consider D = D0(R0/R)α, where R and R0
represent the effective radius of the species and an isolated receptor molecule, respectively.
During each BD time step ∆t, we advance each graph as a rigid body by a distance
l =
√
4D∆te, where D is the lateral diffusion constant of the graph and e is a unit vector
in a random direction. After the lateral translation, we rotate the graph around the center
of mass C by an angle φ = (√3/2√2)(l/R). The direction of rotation is chosen randomly
clockwise or anti-clockwise in each time step. The expression for φ is derived considering
l =
√
4D∆t and φ =
√
2Dr∆t, where l and φ respectively represent the lateral and angular
displacements over time ∆t, D represents the lateral diffusion constant, and Dr represents
the rotational diffusion constant. Again, D and Dr can be related based on Einstein-Stokes
equation, D = KBT/6piµR and Dr = KBT/8piµR, where KB is the Boltzmann constant, T
is temperature, and µ is the membrane viscosity.
2.2.2. Time-Adaptive Advancement of Molecule and Complex Graphs. In each
BD step, we calculate the time step ∆t adaptively. The adaptive ∆t is computed based on
the inter-species distances di, js (Figure 2B). If di, j for any pair of graphs (i, j) is small (i.e.,
an encounter between a pair of graphs is likely), ∆t is chosen small. On the other hand, if
di, j is large for all unique pairs (i, j), ∆t is chosen large to accelerate computation.
To calculate the appropriate size for ∆t, we first compute di, j for all unique pairs
of (i, j) for i , j. As illustrated (Figure 2B), di, j > 0 implies that the corresponding disks
are at non-overlapping positions. On the other hand, di, j < 0 implies that the disks are at
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overlapping positions. We compute the smallest inter-species distance, dmin = min{di, j} for
i , j. If dmin > 0, then none of the disks in the system should be at an overlapping position.
On the other hand, if dmin ≤ 0, at least one pair of disks should be at overlapping positions.
if dmin ≤ 0, i.e., at least one disk pair is overlapping, a collision or reaction could
be imminent. To capture such events more accurately, we consider a fine resolution ∆t
under such conditions. We set the time step, ∆t = l2min/4Dmax , where lmin is the lower
bound on species jumps in our simulation, and Dmax is the diffusion coefficient of the
fastest (smallest) disk in the system. We consider lmin = 1 nm. Thus, all disks advance
by ≤ 1 nm when the probability of a collision or reaction is high. If dmin > 0, i.e., none
of the disks are at overlapping positions, we calculate the shortest possible time (∆ts) that





We then check if ∆ts is too small to consider for computational efficiency. We compare it
with a defined lower bound on time step size, ∆tmin = 10−5 seconds. If ∆ts ≤ ∆tmin, we
disregard ∆ts and set time step ∆t = l2min/4Dmax . However, if ∆ts > ∆tmin, we check if
any specie may advance by a distance greater than lmax = 10 nm, where lmax is an upper
bound imposed on the jump size of species. To ensure that no species violates this upper
bound, we evaluate if
√





Dmax)2 = l2max/16Dmax so that the jump remains within the upper
bound. Otherwise, we set time step ∆t = ∆ts.
2.2.3. Collision, Binding, and Dissociation. A collision may occur if two graphs
occupy conflicting positions as a result of a move. In such a possibility, we simply reject the
move of the particular graph while advancing others. In the model, a binding may occur if a
ligand reaction center and a receptor reaction center fall within a predefined small distance
(reaction layer) lr (19). For each such pair of reaction centers, we consider a probability
of bond formation, k f ≤ 1. We draw a random number between 0 and 1. If the random
number is smaller than k f , we consider the formation of an (implicit) bond between the
reaction centers. In our simulations, we assign lr = 5 Å, a distance comparable to the radius
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of a receptor reaction center. In the model, either lr or k f value can be tuned to make the
system reaction-limited or diffusion-limited. After the bond formation between the reaction
centers, we treat the two associated graphs as a single (larger) graph. As in the existing
nonspatial models (3; 7; 8), we prohibit intra-complex binding (ring formation). A bond
can form only if the reaction centers belong to two distinct species (separate molecules or
complexes).
We consider a dissociation rate constant kr for each ligand-receptor bond. Thus,
the lifetime of each bond is exponentially distributed with mean lifetime λ = 1/kr s. At the
end of each BD step, we calculate the probability of dissociation of each ligand-receptor
bond. We draw a random number between 0 and 1. If the random number is smaller than
1 − exp(−kr∆t), where ∆t is the latest time step, we assume the bond is broken and the
graph is separated into two smaller graphs. In the next step, the separated graphs may move
away from each other because of their diffusion. Alternatively, they may recombine based
on the probability k f to form a complex again. We consider kr = 0.001 s−1 (8). Setting this
parameter to zero makes ligand-receptor binding irreversible. Table S1 in the Supporting
Material summarizes the default values used in the model.
2.3. NON-SPATIAL TRIVALENT LIGAND-BIVALENT RECEPTOR MODEL
We developed a corresponding non-spatial model using the network-free Kinetic
Monte Carlo (KMC) approach (20). The model is based on the earlier models in (7; 8). The
purpose of this nonspatial model was to compare it with the spatial model predictions. Al-
though written in C++, for convenience, we explain this model using the standard notations
of BNGL (21), a rule-based model specification language. The model can be described by
the BNGL rule in Eq. 1. The rule defines the single-site binding and dissociation between
a trivalent ligand molecule L(a, a, a) and a bivalent receptor molecule R(b, b). The ligand
molecule contains three identical reaction centers (binding sites) denoted as a and the re-
ceptor molecule contains two identical reaction centers denoted as b. We use nonspatial
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Table 1. Default parameter values used in the spatial model.
Parameter Comment
A = 1, 000 ×
1, 000 nm
dimension of the plasma membrane domain
nR = 80 molecules
µm−2
density of receptor molecules
nL = 80 molecules
µm−2
density of ligand molecules.
nRsite = 2 number of binding arms in a receptor molecule (bivalent)
nLsite = 3 number of binding arms in a ligand molecule (trivalent)
RR = 55Å effective radius of a receptor molecule
RL = 16.5Å effective radius of a ligand molecule
DR = 104 nm2/s diffusion constant for an isolated receptor molecule
DL = 104[RR/RL ] α
nm2/s
diffusion constant for an isolated ligand molecule
Dt = 104[RR/R(t)] α
nm2/s
diffusion constant for a complex
α = 1 exponent relating diffusivity and size: D∝1/Rα
lr = 5Å reaction layer around each reaction centre
k f = 1 bond formation probability when two reaction centres are within lr
kr = 0.001 s−1 bond dissociation constant
graphs to define these molecules.
L(a) + R(b) ←→ L(a!1).R(b!1) kon, ko f f (1)
The rule above specifies the binding and dissociation between a pair of ligand and
receptor reaction centers. In the rule, the remaining reaction centers of the twomolecules are
not specified. These unspecified reaction centers are wildcards, meaning those could either
be free or connected to other molecules. In the rule, the symbol ! followed by a matching
number (1 in this example) represents a bond connecting the reaction centers. The parameter
kon represents the rate constant for the single-site bimolecular binding (forward reaction).
The parameter ko f f represents the rate constant for the unimolecular bond dissociation
(reverse reaction). The values of these rate parameters are independent of the remaining
reaction centers that are not specified in the rule. These parameters are also independent of
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Table 2. Default parameter values used in the non-spatial model.
Parameter Comment
nR = 80 molecules number of receptor molecules
nL = 80 molecules number of ligand molecules
nRsite = 2 number of binding sites in a receptor molecule
nLsite = 3 number of binding sites in a ligand molecule
kon = 1.67 × 104 nm2/s forward rate constant for single-site binding (this work)
kr = 0.001s−1 reverse rate constant for single-site dissociation
time and size of the species involved. Thus, at any time during the course of a simulation,
the above rule gives rise to an arbitrary number elementary reactions depending on the
number of free reaction centers in different molecules and complexes. It should be noted
that the earlier models in (7; 8) considers an additional rule to describe ligand recruitment
from the solution (extracellular space) to the plasma membrane. In our model, we eliminate
this additional step to make the nonspatial model consistent with the spatial model. This
simplification is based on our assumption that the extracellular solution is well-mixed and
diffusion there is fast compared to diffusion in the cell membrane.
We set ko f f = 0.001 s−1 (8) (the corresponding parameter in the spatial model kr
has the same value). As discussed in the Results section, by comparing the nonspatial
model and spatial model predictions, we determined kon = 1.667 × 104 nm2/s. Table S2 in
the Supporting Material summerizes the default parameter values used in the model.
2.3.1. Code Implementation. Both the spatial and nonspatial models were written
in Object-Oriented C++. The source codes for both models are included in the Supplemen-
taryMaterial (archived folders named “spatial_model.tar.gz” and “nonspatial_model.tar.gz”,
respectively). Detailed instructions for the installation and execution of simulations are pro-
vided in a file named "README.txt" in each folder.
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Figure 3. Simulation snapshots of ligand and receptor clusters in the cell membrane. (A)
nL = nR = 80 molecules/µm2, t = 0 seconds. (B) nL = nR = 80 molecules/µm2, t = 30
seconds. (C) nL = nR = 800 molecules/µm2, t = 0 seconds. (D) nL = nR = 800
molecules/µm2, t = 30 seconds. (E) A zoomed-in region of panel D.
3. RESULTS
3.1. EFFECT OF RECEPTOR DENSITY ON LIGAND-RECEPTOR ASSEMBLY
We first used the spatial model to investigate ligand-receptor assembly at different
levels of receptor densities in the cell membrane. Reportedly, FcεRI copy number in
mast cells may vary between 104 − 106 molecules per cell (22). We wanted to see how
such variations in the receptor expression may affect receptor crosslinking. Figure 3 shows
several snapshots from our simulations. As indicated in the figure, in one casewe considered
a relatively modest level of receptor density, nR = 80 molecules/µm2 (Figure 3A-B). In
the other case, we considered a 10-fold higher receptor density, nR = 800 molecules/µm2
(Figure 3C-E). These densities correspond to 105 and 106 receptor molecules per cell,
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respectively, assuming a spherical cell of 10 µm radius. In both cases, we kept receptor
to ligand ratio 1. In the cell membrane, the ligand density cannot exceed twice the FcεRI
density because a single FcεRI can bind at most two ligandmolecules at a time. By choosing
this ratio, we allowed adequate receptor crosslinking. Figure 3A and Figure 3C respectively
show snapshots corresponding to the above two receptor densities at t = 0. Figure 3B and
Figure 3D show corresponding snapshots at t = 30 seconds after the ligand addition. Both
cases indicate finite-sized receptor aggregation at t = 30 seconds. Not surprisingly, the
higher density case shows relatively larger aggregate formation. However, the formation
of larger aggregates also came at the expense of lesser mobilities. If continued longer, the
aggregates in both cases would further grow but at relatively slow rates. The dynamics
in the high-density case would be rather slower due to the more sluggish motion of the
larger aggregates. In these simulations, we set α = 1. Therefore, the diffusivities of the
aggregates changed naturally (based on the Einstein-Stokes equation). As discussed in the
next section, even such natural decrease in diffusion led to a sharp decay in their mobility
for further growth and aggregation.
Figure 4. Experimental data adapted from Figure 2C of Shelby et al.(14). The Y-axis
represents normalized diffusion coefficient of species in the plasmamembrane of rat basophil
leukemia (RBL)-2H3 cells. The X-axis represents stimulation time. Time zero is the time
of addition of a multivalent ligand. The data were acquired by tracking single-molecule
trajectories in the plasma membrane of 11 distinct cells using superresolution microscopy
(14).
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3.2. TEMPORAL EVOLUTION OF SPECIES DIFFUSIVITY
In a recent experimental work, Shelby et al. (14) investigated the post-stimulation
change in the diffusion of multivalent ligand-crosslinked FcεRI in the plasma membrane of
RBL-2H3 cells. Using super-resolution fluorescence microscopy techniques, they tracked
individual FcεRI aggregates and their diffusion rates after stimulation of cells with multiva-
lent DNP-bovine serum albumin (DNP-BSA). Their measurements showed rapid exponen-
tial decay in the overall species diffusion rate after stimulation with the antigen (Figure 4).
The data indicated more than an order of magnitude decrease in the post-stimulation species
diffusivities. A direct comparison between this data (Figure 4) and our simulation is not
possible due to unknown parameters, which include stimulation dose, antigen structure,
and antigen valencies. However, we wanted to explore if our model could qualitatively
predict similar decay in species diffusivities. Figure 5A shows our model-predicted decay
in the species diffusion after stimulation with the trivalent ligand. Figure 5B shows the
corresponding time-evolution of the species sizes (effective radii). These results are ob-
tained by using the default parameter values listed in Table S1 (Supporting Material). In
Figure 5A, the diffusion constants of the time-evolving species are shown by the horizontal
lines of distinct colors. The length of these lines indicate the lifetimes of the corresponding
species. The start and end of each line indicate the time of appearance and disappearance
of a species, respectively.
The mean diffusivity, which was obtained by averaging the diffusion constants of
all species, indicates a rapid exponential decrease in mobility of the receptor aggregates
immediately after stimulation. The result is consistent with the data of Shelby et al. (14)
(Figure 4). This rapid decrease is due to the fast growth of the initial species, which
were relatively small and short-lived. The rate of decay eventually plateaued down as the
larger aggregates populated at the expense of the more mobile smaller aggregates. The
larger aggregates were relatively long-lived because they were less mobile and the system
transitioned into a more dilute regime, as the interspecies distances became large.
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Figure 5. Temporal changes in species diffusion after stimulation.(A) Diffusion constants
of individual receptor species (a single receptor molecule or a cluster). D and D0 stand for
the diffusion constants of an arbitrary receptor species and an isolated receptor molecule,
respectively. Each horizontal line of a distinct color represents a distinct receptor species
of a finite lifetime. The thick dark line represents the mean diffusivity averaged over all the
receptor species. (B) The sizes (effective radii) of individual receptor species are shown by
the horizontal lines of distinct colors. R and R0 stand for the effective radius of an arbitrary
receptor species and a single isolated receptor molecule, respectively. The thick black line
represents themean size averaged over all receptor species. (C) Effect of receptor expression
on the mean diffusivity. ρR indicates receptor density normalized by the nominal density
nR = 80 receptors/µm2 (Table S1). (D) Effect of the probability parameter k f (Table S1)
on the mean diffusivity.
We then explored how receptor expression levelmay affect the dynamics (Figure 5C).
At low receptor densities, the rate of decay of diffusion became slower (Figure 5D). This is
expected because the larger interspecies distances in a dilute regime involved a less frequent
encounter among the species. A reduced k f also resulted in a slower decay in the diffusion
(Figure 5D). At a small k f , the system became more reaction-limited leading to many
unproductive encounters among the species.
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Figure 6. Comparison between the spatial and nonspatial model. (A) Amount of bound
ligand (to receptors) vs time when ligand-receptor binding is irreversible in both models
(kr = ko f f = 0). Red and black correspond to the nonspatial and spatial model, respectively.
(B) The same as in Panel A considering reversible binding (kr = ko f f = 0.001 s−1). (C)
The nonspatial model-predicted receptor aggregate size distribution at t = 500 seconds.
The distribution was created by grouping receptor aggregate sizes into different bins. Each
bin indicates the range of aggregate sizes in terms of the number of receptor molecules.
The Y-axis represents the normalized amount of receptors corresponding to each bin.
The distribution represents samples from 1,000 simulation runs. The simulations were
performed using the default parameter values listed in Table S2. (D) The spatial model-
predicted receptor aggregate size distribution at t = 500 seconds. The distribution was
created in the same way as in Panel C. The simulations were performed using the default
parameter values listed in Table S1. (E) The same as in Panel C when k f is reduced by
10-fold. (F) The same as in Panel D when α = 0.
3.3. SELF-LIMITING RECEPTOR CROSSLINKING AND AGGREGATION
The nonspatial models in the past indicated that FcεRI crosslinking by a trivalent
ligandmay lead to the superaggregate formation in the cellmembrane (3; 7). We investigated
to what extent the predictions of our spatial model might agree with the predictions of a
nonspatial model. However, a direct comparison between the spatial and non-spatial model
was not possible. In the spatial model, explicit diffusion and steric collisions determine
receptor crosslinking. The non-spatial model lacks these features. In the nonspatial model,
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the association constant (kon) implicitly accounts for the diffusion and steric effects, as
in any typical bimolecular reaction. This parameter is time-invariant and identical for all
species regardless of their size or geometry. To make the spatial and nonspatial model more
Figure 7. Self-limiting aggregation of receptors. The distributions correspond to simulation
time t = 500 s. (A) α = 2, (B) α = 3. Other parameter values used in the simulations are
listed in Table S1.
comparable, we first used the spatial model to predict the kinetics of ligand binding under
two distinct conditions: irreversible binding (kr = 0) (Figure 6A) and reversible binding
(kr = 0.001 s−1) (Figure 6B). We then fitted the nonspatial model to these predictions to
evaluate kon (Figure 6A-B). We found the two models agreed well at kon = 1.67 × 104
nm2/s.
We then used both models to predict the distribution of receptor aggregates at t =
500 seconds. This simulation time was chosen to ensure that the mean distribution reached
the steady-state condition. Similar to the earlier models (3; 7), the nonspatial model
predicted superaggregate formation where a single complex incorporated approximately all
43
receptormolecules (Figure 6C). In contrast, the spatial model predicted remarkably different
distribution showing finite-sized receptor aggregation over awide range of sizes (Figure 6D).
To check if the nonspatial model could also predict finite-sized aggregation at a lower kon,
we reduced the parameter by 10-fold. However, the model still predicted superaggregate
formation as shown in Figure 6E. We found that the nonspatial model required ∼ 100-fold
reduction in kon to predict finite-sized receptor aggregation (result not shown). We then set
α = 0 and allowed the spatial model to predict the distribution. At α = 0, the spatial model
predicted superaggregate formation like the nonspatial model (Figure 6F). In fact, at α = 0,
the spatial model becomes more akin to the nonspatial model because the diffusivities of all
species become time-invariant and identical. This is similar to the nonspatial model where
the bimolecular association constant kon is time-invariant and independent of the species.
We next investigated the distribution of receptor aggregates at α > 1. An earlier
experimental study by Menon et al. (23) demonstrated a dramatic loss of motion of FcεRI
clusters containing more than two receptor proteins. Recently, Mahajan et al. (8) also
reported a similar finding. These reports indicate that the diffusivity of the crosslinked
receptors in the membrane may not exactly follow the natural size-dependence (α = 1).
Theremight be anomalous effects giving rise to the sharp fall in the diffusivity of crosslinked
receptors. In our model, we attempted to capture this effect by setting α > 1. Because
D ∝ 1/Rα, α > 1 makes the diffusivity decay relatively faster. Figure 7A and B show the
distributions at α = 2 and α = 3, respectively. These values led to narrower distribution
peaks and smaller receptor aggregate sizes as compared to the distribution in Figure 6D
(α = 1).
4. DISCUSSION
In this work, we have presented a spatiotemporal model of multivalent ligand-
receptor assembly in the cell membrane. Using the model, we provided a detailed analysis
of the potential roles of membrane diffusion in multivalent receptor assembly. Based on
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(8), we took FcεRI aggregation by a trivalent antigen as a model system for our analysis.
However, the insights gained from the analysis may be generalized for other multivalent
ligand-receptor systems as well. Multivalent ligand-mediated FcεRI aggregation is perhaps
the most thoroughly studied problem in the context of the antigen-receptor interaction.
Pioneering experimental works have been led by the Baird and Holowka laboratory and
complementary modeling works have been done by scientists at the Los Alamos National
Laboratory for decades (9; 23; 24; 25). Nonetheless, with the advent of new quantitative
measurement tools and high-resolution microscopy techniques, many of these earlier works
have been revisited (7; 8; 14).
Our study was primarily inspired by a caveat that most of the existing multivalent
FcεRI aggregation models are nonspatial. This motivated us to develop the spatial model
and investigate if incorporation of space could explain the experimentally-observed phe-
nomena in FcεRI aggregation. To the best of our knowledge, this work introduces the
first spatiotemporal model of multivalent ligand-mediated FcεRI assembly in the cell mem-
brane. The Brownian Dynamics-based simulation approach used in the model is based on
our recent work where we studied a generic multivalent ligand-receptor interaction (15).
The simulation approach explicitly accounts for the coarse-grained structure of the time-
evolving species, their diffusion, and steric collisions. An early model by Goldstein et al.(3)
focused on equilibrium FcεRI aggregation in response to a trivalent ligand. This theoretical
model was not capable of tracking the evolution of individual molecules or complexes. A
later model by Monine et al. (7; 26) allowed this capability by implementing a Kinetic
Monte Carlo (KMC) approach, called network-free simulation (20). The network-free ap-
proach combined with the rule-basedmodeling (RBM) (21; 27) provides a unique capability
to model multivalent species interactions in signaling network system (26). However, the
models developed in this approach are nonspatial. Both the models in (2; 19) indicated
large FcεRI superaggregate formation in response to the trivalent antigen. The more recent
model of (8) was also developed using the nonspatial network-free approach. However,
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the model prohibited superaggregate formation with the assumption that receptor clusters
above a certain threshold size are immobile, whereas all clusters smaller than that threshold
are equally mobile in the membrane.
While addressing the limitation of the nonspatial models above, our work provides
important insights into the potential roles of membrane diffusion on immunoreceptor signal-
ing. The key message from our analysis is that the membrane diffusion may limit receptor
crosslinking and activation against stimulation by antigens. Earlier modeling studies pos-
tulated that FcεRI superaggregate formation may enable cells to become hyperresponsive
against multivalent foreign antigens (3). In contrast, our analysis in Figure 6 and Figure 7
indicates that the diffusion barriers limits receptor clustering, which may contain a cell from
being hyperresponsive. Similar to the earlier models, our model lacks receptor trafficking
in the plasma membrane. We consider a fixed amount of FcεRI and we do not incorporate
receptor synthesis, endocytosis, recycling, or degradation. However, the potential effects
of receptor trafficking in the model could be surmised. Receptor endocytosis might further
put a restriction on receptor aggregation sizes. If receptors have a finite lifetime in the
membrane, it would be less likely for the slowly-diffusing receptor clusters to combine
and form large aggregates. This may further diminish the possibility of a superaggregate
formation. In our model, we analyzed receptor size distribution at 500 seconds after stimu-
lation. We did not see appreciable changes in the distributions at t > 500 seconds even at
α = 1. However, if infinite receptor lifetime is allowed in the absence of endocytosis and
a sufficiently small rate for the bond dissociation is assumed, it is theoretically possible to
form superaggregates in the spatial model.
We limited the scope of our model to the simple ligand-receptor system in two
dimensions. The approach could be extended for spatiotemporal modeling of more com-
plex signaling network systems. A three-dimensional extension of the approach might be
required to more realistically model the extracellular and intracellular compartments of a
cell. However, such an extension entails additional measures to address the computational
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challenges which were beyond the scope of this work. We believe that the predicted ef-
fects of diffusion on the receptor aggregation would remain similar if a three-dimensional
membrane was considered in our model.
Currently, there exists no suitable modeling tool for spatiotemporal modeling of sig-
naling network systems considering the site-specific features of cellular proteins. Although
the RBM approach enables site-specific features and interactions of protein molecules,
most of the RBM tools currently rely on nonspatial graphs to define these features. Recent
efforts have been undertaken to enable spatiotemporal modeling in several rule-based tools,
which include Kappa (28), Simmune (29), and BioNetGen/Smoldyn (30). An extension
of our modeling approach into three dimensions may create additional opportunities for
spatiotemporal modeling of biochemical network systems.
DATA AND CODE AVAILABILITY
The source codes for both spatial and non-spatial models are included in the Sup-
plementary Material (folders named “spatial_model.tar.gz” and “nonspatial_model.tar.gz”,
respectively). Detailed instructions for the installation and execution of simulations are
provided in a file named "README.txt" in each folder.
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Cell radius and endocytic components (transporters) are important factors for
cellular particle uptake in mammalian cells. The level of expression of these transporters in
individual cells determines the cell-to-cell variability in uptake rates. In this work, we study
the effect of cell size and transporter density in plasma membrane through experimental
and mathematical modeling investigation. Nanoparticle uptake can occur in several ways
in a cell and the most important pathways are endocytosis pathways which include clathrin,
caveolae, macropinocytosis, and so on. Nanoparticle mostly enters into the cells through
these pathways and particle internalization happens inside the cell by endocytosis vesicle
formation. In this study, we analyzed breast cancer cell(MDA-MB 231) experimental data
to understand the effect of transporters with different cell size. our study reveals that
with increasing cell size, the overall particle uptake is increasing, however, particle flux
calculating based on surface area is decreasing significantly. We have formulated time-
dependent particle uptake model based on a flow cytometer and confocal microscopy data.
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The model captures cell size and the level of transporter expression in the cell plasma
membrane. The model accurately predicts the kinetic and steady-state particle uptake
behaviors of MDA-MB 231 cancer cells in a cell culture medium.
Keywords: Particle flux,Transporter, Flow cytomter, Endocytosis, Exocytosis
1. INTRODUCTION
Nanoparticle-based cancer therapy is an emerging research area, however, the poor
knowledge of cellular properties is the major problem in this field. The plasma membrane
is the key connection that transfers the core substances (nutrient, bio-molecules, proteins,
and metabolites) inside the cell. The number of substances in a cell depends on endocytosis
(clathrin, caveolae, macropinocytosis, and so on) as well as exocytosis at a specific time (1;
2; 3). Exocytosis pathway is a process that releases the substances out of the cell. For this
reason, the kinetics of nanoparticle uptake play a vital role in cancer treatment.
In the past works, there is no significant evidence for cell size-dependent particle
uptake study. One of the possible reason may be, the internal functionality of a single cell
is complicated. The common idea of cellular uptake is either based on the cell surface
or cell mass. However, in our earlier work(4), we established the steady state reaction-
diffusion model where the particle uptake of MDA-MB 231 cell population follows the
linear relationship with cell size. In this study, we are focusing on cellular properties such
as cell size and endocytic components (transporters) in the cell plasma membrane that are
mostly affecting particle uptake mechanism (5).
The endocytic molecule that can be called as the “transporter” molecule plays
a critical role in particle uptake(5; 6; 7) mechanism in a single cell. The number of
transporter molecule may vary with different cell size and cell type. In the past few years,
several works have been published to understand the endocytosis and exocytosis pathways
and their intrinsic nanoparticle or biomolecule internalization process (8; 9; 10). However,
these studies are very much limited in mammalian cells. Recently, Wang et al. (11) showed
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the linear correlation between nanoparticle uptake and cell size in human mesenchymal
stem cells (hMSCs) which is consistent with our earlier published work. Furthermore,
particle flux (per unit cell surface area) in the plasma membrane is reducing with increasing
cell size and this may happen due to less number of transporter molecule in the cell.
In this work, we investigated how cell size and transporter density depend on cellular
uptake at the single cell level. Here, we are focusing on uptake behavior based on transporter
expression and cell radius. Based on the analysis of our experimental data and parameter
values, we formulate a kinetic model of particle uptake by single cells. We also characterize
their interdependencies. The model captures cell size and the level of transporter expression
in the cell plasma membrane. The model accurately predicts the kinetic and steady-state
particle uptake behaviors of MDA-MB 231 cancer cells in a cell culture medium. For
experimental purpose, we carry out confocal microscopy, dynamic light scattering, and
flow cytometry-based on standard operating protocols. By analyzing both experimental and
model, the parameter values can define the nanoparticle uptake behavior in a single cell.
2. MATERIALS AND METHODS
2.1. CELL CULTURE
MDA-MB 231 cells were grown in RPMI 1640 medium (Roswell Park Memorial
Institute 1640 media, Corning™ cellgro™ Mediatech, Inc. Manassas, VA) supplemented
with 10% Fetal Bovine Serum (Gibco™ Life Technologies, Grand Island, NY), and 1%
penicillin/streptomycin (Gibco™). Cells were kept in a humidified incubator at 37°C and
5% CO2 and split at 70-80% confluence, using 0.25% trypsin-EDTA solution (Gibco™).
For flow cytometry experiments, cells were seeded in 24-well plates. Each well was
added with 1 mL media (100,000 cells per mL of RPMI 1640) and incubated for 24 hours
to allow cell attachment. After the incubation, the media in each well was replaced with a
solution of nanoparticles in RPMI 1640. Here, we used 100 nm polystyrene nanoparticle
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and the concentrations of the nanoparticle are 20µg/mL and 200µg/mL. The cells were
incubated with the nanoparticle solution and the flowcytometry experiment is conducted
with different time until it reached to the steady state condition. For low concntration,
it reached to steady state condition after three hours and 5 hours for higher concentrated
nanoparticle solution.
For confocal microscopy experiment, cells were seeded in 8-well glass bottom
plates. Each well has same density cell with same concentration with same incubation time
as the 24-well plates. After 5 hours incubation, each well was washed thrice to remove free
nanoparticle.
2.2. NANOPARTICLE PREPARATION
Green fluorescent polystyrene nanoparticles (Thermo Scientific™ Fluoro-Max, Fre-
mont, CA) were used without further modification and purification. The particles had a
mean size (diameter) of 100 nm. Particle stock solutions were stored in accordance with the
manufacturer’s instructions. Dynamic light scattering (DLS) was used to confirm particle
size. Before the uptake experiment, the particle solutions were vortexed and sonicated in
accordance with the manufacturer’s recommendations. For use in the DLS measurements
(Zetasizer Nano ZS, Malvern Panalytical, Westborough, MA), the sample stock solutions
were diluted with DI water to maintain the specific concentrations recommended in the
Zetasizer protocol.
Working particle solution was prepared by diluting the stock solution with DI water
at room temperature. The solution was then further diluted in RPMI 1640 media and




For time series data, cells were washed three times with Phosphate-buffered saline
(PBS) and detached with 0.25% trypsin-EDTA (Gibco™). The cell suspension was mixed
with 500 µL of fresh RPMI1640 media solution for flow cytometric measurement. Mea-
surements were performed using a BD Accuri C6 plus (Becton Dickinson, Franklin Lakes,
NJ) with a 488 nm argon-ion laser. Fluorescence (FITC) data was collected through 533/30
nm bandpass filter. At least 100,000 events per sample were taken for analysis. A forward
scatter (FSC) vs. 90side scatter (SSC) log-log plot revealed two distinct populations, one
with low SSC and FSC and the other with high SSC and FSC. The former was understood
to be dust or debris and discarded while the latter, which accounted for over 80%of the data,
was used for analysis(12; 13).
2.4. CELL SIZE ESTIMATION FROM FSC
TheBDAccuriC6 pluswas used to collect forward scatter (FSC-A) data for amixture
of standard fluorescent particles ofmean diameter 2 and 3 µm. The data revealed two distinct
peaks corresponding to the two particle sizes. The size of individual MDA-MB 231 cells
was then estimated from linear extrapolation: cell size (µm) = 3 + (Fc − F3)/(F3 − F2),
where Fc, F2, and F3 represent the FSC peak intensities of the MDA-MB 231 cells, 2 µm
bead, and 3 µm bead, respectively.
2.5. CONFOCAL MICROSCOPY
After 5 hours incubation, cells were washed three times with Phosphate-buffered
saline (PBS) and detached with 0.25% trypsin-EDTA (Gibco™).The cell suspension was
mixed with 500 µL of fresh RPMI1640 media solution MDA-MB 231 cell suspension on
a cover glass was imaged using a Nikon A1R HD25 confocal microscope with a 100X
objective lens. Images were analyzed using the ImageJ software to quantify the size
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Figure 1. Cell size calculation with confocal images and FSC-A data. (A) 2µm and
3µm bead size FSC-A data are being used to calculate the actual cell size. In Figure 1A
represents the distributions of two bead sizes and MDA-MB 231 cells. By using bead
size data, FSC-A based cell size is calculated. (B) Particle uptake based on different
concentrations. Green represents autofluorescence and on the other hand, black,and green
represents particle uptake for two different concentrations(20µg/mL and 200µg/mL). (C)
Surface attached MDA-MB 231 cells image is taken by confocal microscopy. Orange and
pure green color represent the internalized and plasma membrane associated particle in
the single cell whereas the blue color represents the nulcleus. (D) MDA-MB 231 cell
size distribution estimated from flow cytometer (FSC-A) data. The distribution represents
calculation based on 100,000 cells. MDA-MB 231 cell size distribution obtained from
confocal microscopy images (black) and FSC-A-based calculation (green). The shifted
(corrected) FSC-A-based distribution is shown in red.
of individual MDA-MB 231 cells. For 3D confocal imaging, cells were washed three
times with Phosphate-buffered saline (PBS) and fixed cells with imaging kit from fisher
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scientific™. We Put actin (red) and nucleus (blue) stains in the fixed cells and took z-stack
image for a single cell. For this purpose, we used 100x objective of Nikon A1R HD25
confocal microscope.
2.6. MODEL IMPLEMENTATION
The kinetic model for the particle uptake in a single cell showed in detail derivation
the Supporting Material (S1 File). The model was implemented in Matlab.
3. RESULTS
3.1. CELL SIZE AND NANOPARTICLE UPTAKE
We carried out flow cytometer measurement to identify the correlation between
MDA-MB 231 cell size and nanoparticle uptake. Measurements were done to acquire
the forward light scatter (FSC-A) and the fluorescence intensity of the cell-internalized
nanoparticles in single cells. The FSC-A was converted into the cell size, which was
then mapped to the particle uptake (fluorescence intensity of the internalized particles).
FSC-A peaks of two standard fluorescent beads and the MDA-MB 231 cells are shown in
Figure 1A. In Figure 2A, MDA-MB 231 single cell image is demonstrated. The green,
red, and blue color indicates 100 nm particle, actin filament and nucleus respectively. For
calculating actual cell size, around 1000 cells image has been taken using confocal mi-
croscopy and few representative cells image shown in Figure 2B. Similar to our earlier
work, Figure 1 shows the conversion of the FSC signal into cell size in supplementary
figure. we showed nanoparticle uptake distribution for two different concentration is shown
in Figure 1B. The green,black,and pink area indicate concentration of 0µg/mL (cell auto
fluorescence),20µg/mL, and 200µg/mL respectively. A significant shift of the cellular up-
take distribution is visible with various particle concentration. The cell size distribution
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Figure 2. 100 nm particle uptake in MDA-MB 231 cells. (A) Confocal image for single
MDA-MB 231 cell. Green represents 100nm particle, blue represents the nucleus and
finally, red represents actin filament (B) An confocal image showing a few representative
MDA-MB 231 cells.
is shown in supplementary figure Figure 1D. The flow cytometer data suggests that MDA-
MB 231 cells size distribution can be approximated to a lognormal distribution with mean
cell size 〈r0〉 ∼ 10.5 µm and standard deviation σc = 0.20. To check the reliability of
the FSC-based estimate, we also calculated cell size directly from confocal microscopy
images (Figure 2B). The comparison between the FSC-based estimate and the actual cell
size (confocal microscopy image-based calculation) indicates that the FSC provides a slight
overestimate. Nevertheless, it provides a pretty accurate estimate for the peak width (distri-
bution variance). After shifting, the FSC-based distribution showed good agreement with
the actual cell size distribution (Figure 1D). Because the microscopy data corresponds to a
relatively small sample (500 cells), we used the shifted distribution as the correct measure
of cell size distribution. The mean and standard deviation of the distribution of the shifted
distribution are 〈r0〉 ≈ 7.93 µm and σc = 0.30, respectively. The cell sizes calculated above
were mapped to the corresponding fluorescence of internalized nanoparticles, as shown in
Figure 3A. The figure indicates almost a perfect linear increase in the uptake of 100 nm
59
Figure 3. Flow cytometer analysis reveals a linear correlation between cell size and nanopar-
ticle uptake. The experiment was carried out with 100 nm (diameter) nanoparticles. (A)
Each red point represents flow cytometer-measured single-cell nanoparticle uptake plotted
against corresponding cell size. The uptake is expressed as a normalized quantity, which is
the ratio of the fluorescence intensity of a cell’s internalized nanoparticle (I) to the median
fluorescence intensity of overall cell population. (B) Gray area represents distribution of
the overall cellular uptake based on probability density function (pdf). Red area represents
cellular distribution of particle uptake for 1 µm range cell population shown in Figure 3A .
Log scale is used to represent the Figure 3B. The solid gray and red area variance correspond
to σ21 = 0.124 and σ
2
2 = 0.040, respectively.
nanoparticle with cell size. A linear equation with a lognormally distributed noise shows
an excellent agreement with the experimental data. This observed linear correlation in Fig-
ure 3A can be defined by reaction diffusion model(4) with given cell size distribution. Cell
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radius and endcytotic properties are the most important factor for cellular uptake. Here,
we are defining the endocytotic properties as transporter density. However, we want to
distinguish between these two factors to find which is one affecting more for nanoparticle
uptake. For this purpose, histograms are being plotted for two cases as shown in Figure 3B.
First case, overall cell population (gray area) has been considered that includes both cell
size and transporter density effect. On the other case, we took 1 µm range cell population
shown in Figure 3A as indicated in black lines.The histogram area is represented by the
pink color. There is significant difference in variance values of both cases. Now we will
try to find out the particle uptake rate based on cell surface area by taking each 1 µm range
cell population which considered as independent of cell size. Figure 4 shows the cell size
independent nanoparticle uptake based on cell surface area. Based on cell surface area,
Figure 4A represents the particle flux distribution for 5 µm (gray),7 µm (green) and 10
µm (pink) Cell radius. The particle flux distributions of cellular uptake are shifting toward
left as the cell radius increases. However, in Figure 4B, the particle flux goes downward
as the cell radius increase which follow our reaction-diffusion model. The model states
that transporter,n ∝ rα. Based on the above model, We fitted our particle flux data with
〈J〉/ ¯〈J〉 = (r/r0)α where〈J〉, r, r0,and α can be defined as normalized particle flux, cell
radius, mean cell radius,transporter parameter respectively. After fitting with experimental
data, we get α = −0.8186 that satisfy our earliest model prediction(4). The error bar
is calculated from individual cell population data. From this behaviour, we can say that
transporter density is playing a important role for the cellular uptake.
3.2. KINETIC UPTAKE MODEL
The plots in Figure 4 revealed the importance of the endocytic properties (transporter
density) where cell radius effect assume to be negligible if each 1 µm range cell population
taken as a sample. Here, we present a reaction model to find out the transporter density
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Figure 4. Cell size independence on 100 nm nanoparticle uptake by using cell surface
area. Figure 4A are presented in Log scale whereas Figure 4B are represented in normal
scale. (A) Cellular uptake distribution based on surface area for 5 µm (gray),7 µm (red)
and 10 µm (green) Cell. (B) As we can see, particle flux is decreasing as the cell size
increases.The normalized experimental data are fitted with the following model, 〈J〉/ ¯〈J〉 =
(r/r0)α where〈J〉, r, r0,and α can be defined as normalized particle flux, cell radius, mean
cell radius,transporter parameter respectively. After fitting with experimental data, we get
α =-0.8186 that satisfy our earliest model prediction(4).
effect on cellular uptake, as detailed below.
Particle(solution)+Transporter ↔ Complex → Transporter+Particle(internalized).
Particle (internalized) → Exocytosis
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Figure 5. Kinetic model of nano-paticle uptake in MDA-MB 231 cell. The figure repre-
sents two different concentrations. The X-axis represents time and the Y-axis represents
nanoparticle uptake. The dotted lines are the model prediction and circular markers are
the experimental data. The closed circle data represents the higher particle concentration
(200µg/mL) where the open circle data represents lower concentration (20µg/mL).
Here, we define [n],[S],[ns] and U as a transporter,particle,complex and internalized particle
respectively.Transporter(n) in a single cells interacts with particle solution (S) with forward
and reverse rate constant as k1 and k−1 respectively creating complex (nS).These complex
further forms internalized particle (P) in a single cell at k2.Finally, some of the internalized
particle (U) in a single cell can be removed by exocytosis process at rate of ke. The
internalized particle uptake can be defined by following differential equation:
[n]0 = [n] + [nS] (1)
d[n]
dt
= 0 = −k1 · [n] · [S] + k−1 · [nS] + k2 · [n] (2)
d[nS]
dt
= 0 = k1 · [n] · [S] − k−1 · [nS] − k2 · [n] (3)
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After analyzing equation (3),






Now putting the value [ES] in equation (1),
[n] = [n]0 · KM
KM + [S] (5)
Now putting the value [n] in equation (4),
[nS] = [n]0 · [S]
KM + [S] (6)
Now the particle uptake with time
d[U]
dt
= k2 · [nS] − ke ·U (7)
After solving the differential equation (7), we get
U = (k2 · [n]0/ke) · ([S]/(KM + [S])) · [1 − e−ke ·t] (8)
The transporter concentration can be defined by the surface area,
[n]0 = 4 · pi · r¯2 · n (9)
However, according to our earlier work, n ∝ rα . So the final equation becomes,
U = (4 · pi · k · k2 · r¯2+α/ke) · ([S]/(KM + [S])) · [1 − e−ke ·t] (10)
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At steady state, the particle flux can be represented by following equation:
〈J〉 = U/(4 · pi · r2 · τ) (11)
3.3. ESTIMATION OF KM VALUE
At steady state,for two different concentration equation (7) can be written as follow-
ings
0 + ke ·U1 = k · [S1]KM + [S1] (12)
0 + ke ·U2 = k · [S2]KM + [S2] (13)







KM + [S1] (14)
From experimental data at steady state condition:
U1 = 86036.91, S1 = 20µg/mL
U2 = 544210.23, S2 = 200µg/mL
Putting the values of U1, U2, S1, and S2 in equation (13), we get
KM = 289.838
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Figure 6. Model prediction for particle uptake kinetics with a specific cell size. The curves
in each panel correspond to a concentration of 200µg/mL nanoparticle. The dotted line line
represents the model prediction where the markers are representing as experimental data.
Here, 6µm (closed square), 8µm( closed triangle),and 10µm (closed circle) cells have been
shown excellent agreement with model prediction.
3.4. OVERALL PARTICLE UPTAKE KINETICS IN MODEL AND EXPERIMEN-
TAL DATA
We first investigated how particle uptake varies with time when different levels of
particle concentrations are imposed in the extracellular medium. Here, we are considering
the overall cell population. As shown in Figure 5, two different nanoparticle concentrations
were studied for a time series experiment. In this case, the cell radius sample varies from
3 to 13 µm. As shown in Figure 5, particle uptake reached the steady state condition at 3h
and 5h in respective particle concentration (20µg/mL, and 200µg/mL) and calculated KM
based on equation(7). In this figure, dotted lines are the model prediction based on equation
(7) and the markers are the experimental data points. The model and the experimental data
is fitting very well for both cases and the r2 value is around 0.99. The parameter values
of ke and k2 · k for the kinetic mathematical model has an excellent match in the both
concentrations. The kinetic model is being fitted with the experimental data by MATLAB
curve fitting toolbox. The fitted parameter values are shown in Table. 1.
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Table 1. Parameter values for the kinetic model.
Parameter Value Comment
〈r0〉 (µm) 7.93 Cell population-averaged cell size (radius).
σ2c 0.0225–
0.25
Cell size (r0) distribution variance: ln(r0) =
ln〈r0〉 + σcN(0, 1) .
α -0.8186 Parameter correlating cell size (r0) and mean cell-
surface transporter density n˜: n˜/〈n〉 = (r0/〈r0〉)α
kM
(µg/mL)
289.83 Michaelis-Menten rate constant for particle re-
cruitment and detachment by a transporter
ke (s−1) 0.03046 Exocytosis rate constant for particle
k2k
(µm−1s−1)
0.36 Rate constant for particle internalization
3.5. MODEL PREDICTION IN PARTICLE UPTAKE IN A SPECIFIC CELL SIZE
Now, In Figure 6, we want to see the effect specific cell size effect on cellular
particle uptake. In this purpose, time series data for each specific cell size compared with
the model prediction as shown in Figure 6. The dotted lines are the model prediction and
the markers are the experimental data. Here, we showed three specific cell size such as 6
µm (closed square),8 µm( closed triangle),and 10 µm (closed circle) cell radius. The model
prediction shows excellent agreement with normalized particle uptake experimental data.
In this model prediction, we used the fitting parameter α from Figure 4B and parameters
estimated from Figure 5.
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4. DISCUSSION
In this work, we are mainly focusing on particle flux (uptake per unit cell surface
area) in MDA-MB 231 cells and their governing factors towards a single cell. Cell size and
transporter density are both playing the critical role in cellular uptake(14). We analyzed the
separate effect of these factors. Through our modeling and experimental analysis, we find
out that particle flux is reducing with increasing the cell size.
FSC-A data from flow cytometry experiment does not provide actual measurement
of a cell. For this purpose, we have taken confocal images and calculated the cell size
using image J software.However, the cell size distribution from FSC-A based calculation
and confocal image based analysis shows slight variation. As the confocal image data are
more accurate than FSC-A data, we shifted the cell size distribution according the confocal
image data shown in red at Figure 1D.
To find the effect of transporter density in particle uptake, we analyzed experimental
data to estimate transporter characteristic parameter α using following equation, 〈J〉/ ¯〈J〉=
(r/r0)α, based on our earlier work. The correction shows strong agreement with the nor-
malized data and we get α = −0.8186 that define characteristic parameter of transporters
in a cell. The negative α represents transporter density reduction whereas the positive α
signifies transporter density increment. Similar findings to in our earlier work(4), we found
α negative value signifying that with increasing cell size, the transporter density will reduce.
In this study, we developed a kinetic model for particle uptake. Themodel represents
the biochemical interaction between the nanoparticle and endocytic molecules in the plasma
membrane and their internalization process(15; 16). We also incorporated the exocytosis
effect in our model. But we did not include the diffusion phenomena in our work as we
showed in our earlier paper that it does not affect the particle uptake significantly. However,
the flow cytometry experimental data shows excellent agreements with our established
model prediction. We fitted this model in two separate particle concentration based mean
68
particle flux uptake and and the estimated parameter are used to generate model prediction
for specific cell size dependent particle flux. In this both concentration, the mathematical
model showed robust parameter estimation.
Recently, several published article(4; 11) reported that the particle uptake shows
linear correlationwith cell size. Our experimental analysis are consistent with their findings.
According to wang et al. (11) article, they showed the results based on human mesenchmal
stem cell (hMSCs) and this cells were cultured in micro-patterned surface. on the other
hand, our MDA-MB 231 cells are grown in a normal cell culture flasks. However, in this
study the authors reported that the larger cells exhibit lower quantity of particle per unit
cell surface area in the plasma membrane. This analysis is consistent with this work shown
in Figure 4B. We further investigated this analysis into specific cell size-dependent particle
flux. This analysis helps us to find out the transporter density quantitatively. In our study,
we showed that the decrease in particle flux reflects a reduced transporter molecule per unit
area of the plasma membrane.
In a single cell, particle uptake mainly depends on many factors associated with
complex endocytosis, exocytosis, and intracellular trafficking pathways as described in(2;
5; 17). The cellular level particle uptake also governed by other factors such as diffusion, cell
type-specific quantitative information, and incorporation. It is not possible to incorporate
all these factors in our kinetic model as the addition of all these factors will need more
parameter estimation and uncertainty in model prediction. Therefore, the net contributions
from these individual factors are often homogenized into an effective rate of uptake and the
entire uptake process can be simplified into simple kinetic model (18; 20; 21; 22; 23; 24; 25).
In our work, we ignored the individual factors associated with distinct pathways. Instead,
we divided the uptake process into two steps. The first step is particle interaction uptake
by a generic transporter molecule in the plasma membrane and internalization process of
particle inside the cell. And the second step is associated with exocytosis of particles from
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the cell. We also ignored the diffusion of the particle from extracellular media as we already
showed that diffusion of particle did not have any significant effect in cellular level particle
uptake.
Finally, our study emphasizes undecrstanding cellular uptake processes at the single-
cell level. The analysis shows that the rate of nanoparticle uptake by single cells is tightly
coupled to the endocytic components (transporters) in the cell plasma membrane as well as
cell radius. Here, using quantitative single-cell experiments and modeling, we investigate
these two parameters in determining the overall heterogeneity in nanoparticle uptake by
MDA-MB 231 breast cancer cells. We also characterize their interdependencies.The model
captures cell size and the level of transporter expression in the cell plasma membrane. The
model accurately predicts the kinetic and steady-state particle uptake behaviors ofMDA-MB
231 cancer cells in a cell culture medium.
SUPPORTING MATERIALS
The file contains a detailed derivation of our model and the matlab script imple-
menting the model.
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ABSTRACT
The size of a cell is central to many functions, including cellular communication
and exchange of materials with the environment. This modeling and experimental study
focused on understanding how the size of a cell determines its ability to uptake nanometer-
scale extracellular materials from the environment. Several mechanisms in the cell plasma
membrane mediate cellular uptake of nutrients, biomolecules, and particles. These mech-
anisms involve recognition and internalization of the extracellular molecules via endocytic
components, such as clathrin coated pits, vacuoles, and micropinocytic vesicles. Because
the demand for an external resource could be different for cells of different sizes, the collec-
tive actions of these various endocytic routes should also vary based on the cell size. Here,
using a reaction-diffusion model we analyze single cell data to interrogate the one-to-one
mapping between the size of the MDA-MB 231 breast cancer cells and their ability to up-
take nanoparticles. Our analysis indicates that under both reaction- and diffusion-controlled
regimes, cellular uptake follows a linear relationship with the cell radius. Furthermore, this
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linear dependency is insensitive to particle size variation within 20- 200 nm range. This re-
sult is counterintuitive because the general perception is that cellular uptake is proportional
to the cell volume (mass) or surface area and hence follow a cubic or square relationship
with the cell radius. A further analysis using our model reveals a potential mechanism
underlying this linear relationship.
Keywords: Diffusion, Physiochemical, Endocytosis, Cancer biology, Nanoparticle
1. INTRODUCTION
Cell size is a critical attribute central to many cellular functions. The plasma
membrane is the sole interface between a cell and the extracellular medium. It mediates
the exchange of nutrients, particles, proteins, biomolecules, and metabolites between the
cell and its environment. Therefore, the size of a cell or the surface area of its plasma
membrane may play a central role in determining the rate of cellular uptake of materials.
The general perception is that cellular uptake is proportional to the volume of a cell because
the demand for the external resources might be determined by the cell mass. However, it is
also argued that uptake is proportional to the surface area of a cell because the extracellular
materials are internalized by a variety of transporter proteins and endocytic structures in
the cell plasma membrane (1; 2). A larger surface area of a cell perhaps implies a more
abundance of these plasma membrane-associated components involved in the recognition,
transport, and trafficking of the extracellular molecules and particles.
Nevertheless, in addition to the cell volume or surface area, several other factors may
also contribute to the uptake characteristics of a cell. For example, the extracellular transport
of a molecule or particle could influence its uptake in a diffusion-controlled environment
(3). Examples of such environments include porous media or biological tissues, where a
variety of barriers may hinder the motion of the molecules and particles (4; 5). On the
contrary, transport could play aminor role in a cell culturemedium, where the limiting factor
could be a cell’s intrinsic ability to process materials via different endocytic pathways (6).
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Therefore, the uptake behavior of a cell may be influenced by the relative rate of diffusion
and reaction (cell-surface recognition and intracellular trafficking). However, the ultimate
uptake characteristics could bemore complicated given the possibility that the size or growth
of a cell may be dictated by its rate of uptake of the extracellular resources and vice versa
(7; 8; 9). Under such circumstances, a feedback-like relationship between cellular uptake
and cell size is expected.
Several works in the past investigated cell size-dependent nutrient uptake by the phy-
toplanktonic organisms (2; 3; 10; 11; 12; 13). These earlier works focused on understanding
how the size of these organisms define their uptake behavior under a limiting nutrient envi-
ronment. However, for the mammalian cells, relevant literature seems surprisingly limited.
As noted earlier, the reason might be that the correlation between cell size and uptake seems
too intuitive to deserve a systematic investigation. In a recent work, Wang et al. (14)
investigated cell size-dependent uptake of nanoparticles in human mesenchymal stem cells
(hMSCs). In this study, a micropatterned surface was used to grow cells of different sizes.
Their experiments revealed a linear increase in particle uptake with cell size. Furthermore,
the larger cells displayed a reduced uptake per unit area of the cell membrane compared to
their smaller counterparts. The authors attributed these observed uptake behaviors to the
higher plasma membrane tension in the larger micropatterened hMSCs.
In recent years, remarkable efforts have been made to understand endocytic recogni-
tion and internalization of biomolecules and nanoparticles (15; 16). However, many of these
studies, inspired primarily by the drug delivery or cancer research, have paid little attention
to the cell size or other cellular attributes at the single cell level. Instead, attention has
been mostly directed to investigating how the physiochemical attributes of the nanoparticles
determine the mean (cell population average) uptake (17; 18; 19; 20; 21; 22; 23; 24; 25; 26).
The size of a nanoparticle (or a cargo molecule) perhaps remains to be the most extensively
studied particle attribute in this context (15; 24; 25; 26; 28). It has been demonstrated that
phagocytosis and micropinocytosis mediate trafficking of relatively larger cargoes in the
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micrometer range. In contrast, clathrin coated pits primarily mediates uptake of smaller
particles in the nanometer range. An earlier work by Rejman et al. (24) demonstrated
that particles larger than 500 nm are internalized predominantly by the caveolae-mediated
pathway, whereas particles smaller than 200 nm size are internalized primarily by the
clathrin-mediated endocytosis. More recently, Zhang et al. (25) demonstrated that 25 -
30 nm particles represent the optimal size range for internalization via the endocytic path-
ways. The review article by Shang et al. (26) provides a detailed overview of particle-size
dependent uptake of nanoparticles in various cell types. Nevertheless, despite these ad-
vancements, it remains poorly understood how the physical attributes of a single cell govern
its ability to uptake particles because the measurements and analysis have mostly focused
on the cell population-average uptake with an interest in the attributes of the particles rather
than cells.
Here, using a reaction-diffusion model, we analyze single-cell data to investigate the
one-to-one correspondence between cell size and particle uptake. Our model incorporates
cellular heterogeneity in cell size and cell-to-cell variability in endocytic capacities. The
model couples these cell-specific attributes to nanoparticle diffusion in the extracellular
medium. Using the model, we investigate cell size-dependent nanoparticle uptake in
the reaction- and diffusion-limited conditions. By analyzing flow cytometry data and
microscopy image analysis, we map the MDA-MB 231 cell size to nanoparticle uptake in a
typical cell culture condition. By model fitting to the experimental, we identify parameters
governing the particle uptake behavior of MDA-MB 231 cells. For a range of nanoparticle
sizes, we show that cellular uptake of particles may vary linearly with cell radius under both
diffusion and reaction controlled conditions. From diffusion theory, such linear relationship
is expected only in the diffusion-limited regime. Nevertheless, our single-cell experimental
data reveals similar behavior in a regular cell culture medium, where the diffusion effect is
expected to be minimal. Based on our analysis, we propose a potential mechanism that can
explain the linear correlation between cell size and uptake in a reaction limited regime.
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2. MATERIALS AND METHODS
2.1. CELL CULTURE
MDA-MB 231 cells were grown in RPMI 1640 medium (Roswell Park Memorial
Institute 1640 media, Corning™ cellgro™ Mediatech, Inc. Manassas, VA) supplemented
with 10% Fetal Bovine Serum (Gibco™ Life Technologies, Grand Island, NY), and 1%
penicillin/streptomycin (Gibco™). Cells were kept in a humidified incubator at 370C and
5% CO2 and split at 70-80% confluence, using 0.25% trypsin-EDTA solution (Gibco™).
For flow cytometry and fluorescence microscopy experiments, cells were seeded in
24-well plates. Each well was added with 1 mL media (100,000 cells per mL of RPMI
1640) and incubated for 24 hours to allow cell attachment. After the incubation, the media
in each well was replaced with a solution of nanoparticles in RPMI 1640. The cells were
incubated with the nanoparticle solution for 5 hours before conducting flow cytometry.
2.2. NANOPARTICLE PREPARATION
Green fluorescent polystyrene nanoparticles (Thermo Scientific™ Fluoro-Max, Fre-
mont, CA) were used without further modification and purification. The particles had a
mean size (diameter) of 100 nm. Particle stock solutions were stored in accordance with the
manufacturer’s instructions. Dynamic light scattering (DLS) was used to confirm particle
size. Before the uptake experiment, the particle solutions were vortexed and sonicated in
accordance with the manufacturer’s recommendations. For use in the DLS measurements
(Zetasizer Nano ZS, Malvern Panalytical, Westborough, MA), the sample stock solutions
were diluted with DI water to maintain the specific concentrations recommended in the
Zetasizer protocol.
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Working particle solution was prepared by diluting the stock solution with DI water
at room temperature. The solution was then further diluted in RPMI 1640 media and
vortexed to ensure uniform mixing. The RPMI 1640 media was pre-warmed to 370C for
better particle dispersion.
2.3. FLOW CYTOMETRY
After five hours of incubation with the nanoparticle-RPMI solution, cells were
washed three times with Phosphate-buffered saline (PBS) and detached with 0.25% trypsin-
EDTA (Gibco™). The cell suspension was mixed with 500 µL of fresh RPMI1640 media
solution for flow cytometric measurement. Measurements were performed using a BD
Accuri C6 plus (Becton Dickinson, Franklin Lakes, NJ) with a 488 nm argon-ion laser.
Fluorescence (FITC) data was collected through 533/30 nm bandpass filter. At least 20,000
events per sample were taken for analysis. A forward scatter (FSC) vs. 900 side scatter
(SSC) log-log plot revealed two distinct populations, one with low SSC and FSC and the
other with high SSC and FSC. The former was understood to be dust or debris and discarded
while the latter, which accounted for over 80% of the data, was used for analysis.
2.4. CELL SIZE ESTIMATION FROM FSC
TheBDAccuriC6 pluswas used to collect forward scatter (FSC-A) data for amixture
of standard fluorescent particles ofmean diameter 2 and 3 µm. The data revealed two distinct
peaks corresponding to the two particle sizes. The size of individual MDA-MB 231 cells
was then estimated from linear extrapolation: cell size (µm) = 3 + (Fc − F3)/(F3 − F2),
where Fc, F2, and F3 represent the FSC peak intensities of the MDA-MB 231 cells, 2 µm
bead, and 3 µm bead, respectively .
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2.5. FLUORESCENCE MICROSCOPY
MDA-MB 231 cell suspension on a cover glass was imaged using a Zeiss Apotome
2 microscope with a 63X objective lens. Images were analyzed using the ImageJ software
to quantify the size of individual MDA-MB 231 cells.
2.6. MODEL IMPLEMENTATION
A detailed derivation of the reaction-diffusion model is provided in the Supporting
Material (S1 File). The model was implemented in Python. The Python code is also
provided in the Supporting Material (S1 File).
3. RESULTS
3.1. CORRELATION BETWEEN MDA-MB 231 CELL SIZE AND NANOPARTI-
CLE UPTAKE
We carried out flow cytometer measurement to identify the correlation between
MDA-MB 231 cell size and nanoparticle uptake. Measurements were done to acquire
the forward light scatter (FSC-A) and the fluorescence intensity of the cell-internalized
nanoparticles in single cells. The FSC-A was converted into the cell size, which was then
mapped to the particle uptake (fluorescence intensity of the internalized particles).
Figure 1 shows the conversion of the FSC signal into cell size. In Figure 1A, FSC-A
peaks of two standard fluorescent beads and theMDA-MB 231 cells are shown. The relative
positions of these three peaks were used to estimate the cell sizes, as described in Materials
and Methods. The cell size distribution is shown in Figure 1B. The data suggests that
MDA-MB 231 cells size distribution can be approximated to a lognormal distribution with
mean cell size 〈r0〉 ∼ 11 µm and standard deviation σc = 0.20.
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Figure 1. Size distribution of MDA-MB 231 cells. (A) From left to right: flow cytometer
forward scatter (FSC-A) peaks corresponding to 2 µm beads, 3 µm beads and MDA-MB
231 cells. (B) MDA-MB 231 cell size distribution estimated from flow cytometer FSC-A.
The distribution represents calculation based on 10,000 cells. (C) An image showing a few
representative MDA-MB 231 cells. (D) MDA-MB 231 cell size distribution obtained from
microscopy images (black) and FSC-A-based calculation (green). The shifted (corrected)
FSC-A-based distribution is shown in red.
To check the reliability of the FSC-based estimate, we also calculated cell size
directly from microscopy images (Figure 1D). The comparison between the FSC-based
estimate and the actual cell size (microscopy image-based calculation) indicates that the
FSC provides a slight overestimate. Nevertheless, it provides a pretty accurate estimate for
the peak width (distribution variance). After shifting, the FSC-based distribution showed
good agreement with the actual cell size distribution (Figure 1D). Because the microscopy
data corresponds to a relatively small sample (1,500 cells), we used the shifted distribution
as the correct measure of cell size distribution. The mean and standard deviation of the
distribution of the shifted distribution are 〈r0〉 ≈ 8 µm and σc = 0.20, respectively.
80
The cell sizes calculated above were mapped to the corresponding fluorescence of
internalized nanoparticles, as shown in Figure 2A. The figure indicates almost a perfect
linear increase in the uptake of 100 nm nanoparticle with cell size. A linear equation with
a lognormally distributed noise shows an excellent agreement with the experimental data.
Figure 2. Flow cytometer analysis reveals a linear correlation between cell size and nanopar-
ticle uptake. The experiment was carried out with 100 nm (diameter) nanoparticles. (A)
Each black point represents flow cytometer-measured single-cell nanoparticle uptake plot-
ted against corresponding cell size. The uptake is expressed as a normalized quantity,
which is the ratio of the fluorescence intensity of a cell’s internalized nanoparticle (I) to the
median fluorescence of a 3 µm fluorescent bead (Ib). The red points represent the following
linear relationship with lognormally-distributed noise: IIb = Kr0e
N(0,σ2t ), where K = 0.046,
σt = 0.263, and N(0, σ2t ) is a normally distributed random variable. (B) Green represents
distribution of the cell autofluorescence (normalized with Ib). Black represents cellular
distribution of particle uptake (measured I/Ib, black points in Panel A). Red represents
distribution of uptake based on the above linear relationship (red points in Panel A).
A recent experimental study have reported similar linear correlation between cell
size and uptake of nanoparticles in micropatterned human mesenchymal stem cells (14).
This observed behavior is, however, unexpected because cell size is expressed in cell radius
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(r0), not in cell surface area or cell mass. It defies the intuition that particle uptake rate
would be proportional to the cell surface area or cell mass. Both defines a non-linear
correlation between the particle uptake rate and r0. If uptake is directly proportional to the
surface area, it can be defined as:
Ûm = ksCb4pir20 eN(0,σ
2
t ) (1)
where, Ûm is the rate of uptake, ks is a constant, Cb is the concentration of nanoparticle in
the extracellular solution, and N(0, σ2t ) is a normal distribution with mean 0 and standard
deviation σt . N(0, σ2t ) accounts the possibility of noise in particle uptake between two cells






where kv is a constant and ρ is the cell density. However, these simple models, which appear
to be physically meaningful, are inconsistent with the linear trend observed in Figure 2A
because uptake rate in these two models is proportional to r20 and r
3
0 , respectively.
In Figure 3 we present two hypothetical cases showing how particle uptake should
vary against cell size according to the above simple intuitive models (Eq. 1 and Eq. 2). In
one case, we consider a widely distributed cell size (Figure 3A and B), while in another case,
we consider a relatively narrowly distributed cell size (Figure 3C and D). In both cases, the
nonlinearities of the noisy curves are evident even though it is more apparent for the wider
cell size distribution (Figure 3B). However, because our measurements (Figure 2) indicate
quite narrowly distributed MDA-MB 231 cell sizes, we also provide a direct comparison
between these nonlinear models and the experimental data. As seen in Figure 4, the
nonlinear models poorly describe the data compared to the linear fit in Figure 2. Note that
the theoretical points in the scatter plots (Figure 4A) appear to be more condensed compared
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to the experimental data. However, an attempt to reduce this discrepancy by increasing
noise (σt) led to greater disagreements between the experimental and the theoretical peaks
in Figure 4B.
Figure 3. Cell size-dependent particle uptake described by two simple nonlinear models.
(A) An assumed distribution for cell size: r0 = 〈r0〉eN(0,σ2c ), where 〈r0〉 = 10 µm represents
the mean cell size and σc = 0.5 represents the standard deviation. (B) Black: uptake
is proportional to cell surface area ( Ûm ∼ ( r0〈r0〉 )2eN(0,σ
2
t )). Red: uptake is proportional to
the cell mass ( Ûm ∼ ( r0〈r0〉 )3eN(0,σ
2
t )). The solid lines and points correspond to σt = 0 and
σt = 0.4, respectively. The cell sizes (X-axis values) are sampled from the distribution in
Panel A. (C) The same as in Panel A for a narrower cell size distribution (σc = 0.20). (D)
The same as Panel B for a narrower cell size distribution (σc = 0.20).
3.2. REACTION-DIFFUSION MODEL
The scatter plot in Figure 2A revealed two distinct types of heterogeneities in particle
uptake by cells. One type of heterogeneity reflects the differences in the cell size, as revealed
by the linear increase in particle uptake with cell radius r0. The other type of heterogeneity is
the noise which probably originates from cell-to-cell variation in the endocytic capacities.
Because the two simple models above were inadequate to describe these variations, we
sought for a more complex model, as detailed below.
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Figure 4. Comparison between the experimental data and the two simple non-linear cases in
Eq. 1 and Eq. 2. (A) The black dots represent the flow cytometer data presented in Figure 2A.
The orange and blue dots are respectively generated using Eq. 1 and Eq. 2, where particle
uptake is assumed proportional to the cell surface area and cell mass, respectively. (B)
Probability distributions corresponding to the points in panel A.
In an earlier work, Pasciak et al. (3) developed a reaction-diffusion model to study
nutrient absorption by the phytoplanktonic organisms. By adopting a similar approach,
we develop a model, where we consider a spherical cell and freely diffusing nanoparticles
in the extracellular space. The diffusing particles are captured and internalized at the cell
boundary. Unlike the model of Pasciak et al. (3), we explicitly consider nanoparticle uptake
by a finite number of endocytic components in the cell plasma membrane. Transmembrane
nanoparticle uptake is mediated by a variety of endocytic vesicles (clathrin-coated pits,
vacuoles, or phagosomes) in the cell plasma membrane (29). We lump together all these
different components into one single (average) component. We assume that there are ne
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such components per unit area of the plasma membrane of a cell. Each such component
on average can handle maximum nt particles at a time. Based on this consideration, we
assume that unit area of the cell membrane contains n = ne × nt number of hypothetical
particle processing units, each of which can handle at most one nanoparticle at a time. We
call each of these hypothetical units a “transporter”.
We consider a reversible interaction between a transporter and a nanoparticle. A
particle captured by a transporter may dissociate and return to the solution, or it may be
taken inside the cell through endocytosis. These steps are described by the following
Michaelis-Menten reaction scheme:
Particle(solution)+Transporter ↔ Complex → Transporter+Particle(internalized).
In the above scheme, the three reactions are associated with the following three rate con-
stants (Table 1): k f is associated with the forward reaction that leads to the formation of
the particle-transporter complex, kr is associated with the reverse reaction that leads to
dissociation of the complex, and k1 is associated with the reaction that leads to particle
endocytosis and regeneration of the transporter.
At steady-state condition, the flux of nanoparticles across the cell membrane can be







Here,C0 represents nanoparticle concentration at the solution-cell membrane interface, and
Jm = k1n represents maximum flux when there are n transporter molecules per unit area







represents the Michaelis-Menten constant. The same form of equation (Eq 3) describes
nutrient flux in the model of Pasciak et al. (3). However, in the Pasciak model, it was
introduced as a phenomenological function, and no mechanism of uptake was described at
the molecule level. In our model, it appears naturally from the interaction between a finite
number endocytic components and their interaction with particles.





where C∗0 = C0/Km and J∗ = J/Jm. We consider a spherical cell of radius r0 and define
dimensionless distance r∗ = r/r0. Now, steady-state mass balance leads to the following
differential equation:
∇ · (D∇C∗) = 0 (6)
where C∗ = C/Km is the dimensionless nanoparticle concentration at r∗ > 1, and D is the





where KB is the Boltzmann constant, T is temperature, µ is the dynamic viscosity of the
extracellular fluid, and a is the particle radius. Due to the symmetry of the spherical
geometry, we assume no gradient in C∗ in the θ and φ directions. The two boundary
conditions for the system are C∗b = Cb/Km at r∗ →∞ and C∗0 = C0/Km at r∗ = 1, where Cb
















= Ψ(C∗b − C∗0) (9)
where Ψ = DKmJmr0 . The net rate of particle uptake by the entire cell,
Ûm = 4pir20 JmΨ(C∗b − C∗0) = 4pir0DKm(C∗b − C∗0) = k(C∗b − C∗0), (10)
where k = 4pir0DKm. From Eq. 5 and Eq. 9, the following quadratic equation is obtained:
C∗0
2
+ (1/Ψ + 1 − C∗b)C∗0 − C∗b = 0 (11)
The solution to this quadratic equation yields nanoparticle concentration at the cell bound-
ary:
C∗0 = −(1/2)(1/Ψ + 1 − C∗b) + (1/2)[(1/Ψ + 1 − C∗b)2 + 4C∗b]1/2 (12)
Again, from Eq. 10, the total particle uptake rate by the entire cell,
Ûm = k
(
C∗b + (1/2)(1/Ψ + 1 − C∗b) − (1/2)[(1/Ψ + 1 − C∗b)2 + 4C∗b]1/2
)
(13)
The model above is deterministic and describes an average (or ideal) single-cell behavior,
as in the nutrient uptake model of Pasciak et al. (3). It does not account for the hetero-
geneity arising from the difference in the cell size or cell-to-cell variability in the endocytic
capacities. We consider a lognormal size distribution for cells: r0 ∼ eN(µc,σ2c ), where
〈r0〉 = eµc represents the mean cell size and σc represents the standard deviation of the
distribution. With this consideration, a larger cell can have more cell-surface transporter
molecules compared to a smaller cell given the two cells have identical transporter density
(n) in the cell membrane.
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However, the above consideration is inadequate to fully describe cellular heterogene-
ity in particle uptake. Two cells of identical size may still differ in their ability to uptake
particles due to the intrinsic transcriptional noise associated with the endocytic pathways.
To incorporate this additional source of noise, we consider a nominal case, where we assume
cell-surface transporter density n varies from cell to cell following a lognormal distribution:
n ∼ eN(µt,σ2t ). Here, n˜ = eµt is the mean transporter density and σt is the standard deviation
describing the noise in n.
Nonetheless, the nominal case above ignores a possibility that n˜ could be dependent
on cell size. Therefore, we consider n˜/〈n〉 = (r0/〈r0〉)α, where 〈·〉 represents the ensemble
average over all cells. The exponent α takes a positive or negative value (α = 0 represents
the nominal case discussed above). The rationale behind this relation is explained later
when the relevant analysis is provided.
With the above considerations, both k and Ψ become random numbers and Eq. 13
takes the following form:
Ûm = Y1
(
C∗b + (1/2)(1/Y2 + 1 − C∗b) − (1/2)[(1/Y2 + 1 − C∗b)2 + 4C∗b]1/2
)
(14)
where Y1 ∼ 4piDKmeN(µc,σ2c ) and Y2 ∼ (DKm/k1)e−(N(µc,σ2c )+N(µt,σ2t )).
3.3. PREDICTED CORRELATION BETWEEN CELL SIZE AND NANOPARTI-
CLE UPTAKE
We first investigated how particle uptake varies with cell size when different levels
of diffusion barriers are imposed on nanoparticle transport in the extracellular medium.
As shown in Figure 5, two different cell size distributions were studied. Figure 5A-B
correspond to a wider cell size distribution, while Figure 5C-D correspond to a narrower
cell size distribution. All parameters were assigned with their nominal values (Table 1)
unless mentioned explicitly in the figure caption.
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Figure 5. Model-predicted correlation between cell size and nanoparticle uptake.The X-axis
represents cell size and the Y-axis represents nanoparticle uptake. The uptake is expressed
as a dimensionless quantity: Ûm/4pi〈r0〉DmCb, where Dm = 4.29 µm2/s represents diffusivity
of a 100 nm particle in water at 250 C (Table 1) and Cb is the particle concentration in the
bulk solution. (A) Each curve represents a different particle diffusivity in the extracellular
medium. Black represents diffusivity in a cell culture medium, where viscosity is assumed
to be 1 cP. Orange, green, red, cyan, and blue respectively represent a 0.1, 0.03, 0.01,
0.003, and 0.001-fold reduced diffusivity relative to the cell culture medium. Cell sizes
are sampled from a lognormal distribution (〈r0〉 = 10 µm, σc = 0.5), and cell-surface
transporter density is assumed to be constant (〈n〉 = 0.119 µm−2, σt = 0, α = 0). (B)
All conditions are identical to Panel A but a noise is incorporated by sampling n from a
lognormal distribution (〈n〉 = 0.119 µ−2, σt = 0.4, α = 0). (C) and (D) All conditions are
identical to Panel A and B, respectively, but a narrower cell size distribution is assumed
(〈r0〉 = 10, σc = 0.2).
All black lines/points in the figure represent particle uptake in a cell culture medium.
We assumed a viscosity of 1 cP and estimated particle diffusion constant using the Einstein-
Stokes equation. As expected, the result indicates that particle uptake in a cell culture
medium occurs in a reaction limited regime. A further decrease or increase in the diffusivity
by 10-fold does not make any noticeable difference. In order for the diffusion effect to be
visible, it requires at least 30-fold reduced diffusivity (green lines/points).
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Figure 5 indicates a nonlinear relationship between the cell size and nanoparticle
uptake rate in the reaction-limited condition. However, this relationship tends to be linear
as the system approaches the diffusion-controlled regime. This could be explained by
interpreting the model equations. Based on Eq. 12, the reaction-limited condition prevails
when
1/Ψ << |1 − Cb ∗ | (15)
Under this condition, particle concentration at the cell boundary tends to be similar to the
bulk concentration (C∗0 ≈ C∗b), and we recover the Michaelis-Menten rate law in Eq. 5 by
replacing C∗0 with C
∗





Moreover, if Km << Cb, this equation reduces to Ûm ∼ r20 , leading to the simple
model in Figure 3, where uptake is proportional to the cell membrane area. On the other
hand, the diffusion effect becomes apparent when 1/Ψ takes a value comparable to |1−C∗b |.
In particular, the diffusion effect becomes more apparent for cells larger than 5 µm. In
contrast when 1/Ψ >> |1 − C∗b |, the system falls into the diffusion-controlled regime, and
C∗0 ≈ ΨC∗b. From Eq. 11, the uptake rate becomes
Ûm = 4pir0DKmC∗b(1 − ψ) ≈ 4pir0DKmCb, (17)
thus leading to the linear correlation between particle uptake and cell size.
In summary, the result in Figure 5 suggests a linear correlation between cellular
uptake in the diffusion-controlled regime. However, the linearity observed in Figure 2 still
remains unexplained because a significant transport barrier is not expected in an in vitro
cell culture medium. Note that the result in Figure 5 represents the nominal case where we
assume there is no correlation between the cell size and the density of transporter molecule
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Table 1. Nominal values for the model parameters.
Parameter Value Comment
〈r0〉 (µm) 10 Cell population-averaged cell size (radius).
σ2c 0.0225–
0.25
Cell size (r0) distribution variance: ln(r0) =
ln〈r0〉 + σcN(0, 1) .
〈n〉 (µm−2) 0.119 Cell population-averaged transporter density
σ2t 0.16 Variance describing the noise in transporter den-
sity n: ln(n) = ln(n˜) + σtN(0, 1).
α 0 Parameter correlating cell size (r0) and mean cell-
surface transporter density n˜: n˜/〈n〉 = (r0/〈r0〉)α
k f
(µm3s−1)
0.1 Forward rate constant for particle recruitment by
a transporter
kr (s−1) 0.1 Reverse rate constant for particle detachment from
a transporter
k1 (s−1) 0.02 Rate constant for particle internalization
D (µm2/s) 4.29 Nanoparticle diffusivity, D = kBT/(6piµrp),
where temperature, T = 298.15 K, B is Boltz-
mann constant, particle radius, rp = 50 nm, and
dynamic viscosity of the extracellular solution,
µ = 1 cP.
in the cell membrane (α = 0). As we will show later, anti-correlation between these two
(i.e., negative value of α) can explain a linear dependency between cell size and uptake rate
in the reaction-limited region as well.
91
3.4. NOISE IN PARTICLE UPTAKE
An interesting thing to note in Figure 5 is that there is a high degree of cellular noise
in particle uptake in the reaction-limited regime. The noise diminishes gradually with an
increasing diffusion effect. To investigate the noise further, we raised the intrinsic forward
rate constant (k f ) in an attempt to drive the system into the diffusion-limited regime. This
change in k f led to a reduced noise, as seen in Figure 6. This suppression of the noise
indicates a reduced influence of n on particle uptake in the transport-limited regime. In
a purely diffusion-controlled regime, uptake becomes independent of n: Ûm ∼ r0DKmCb
(Eq. 17). Therefore, the relationship appears deterministic. On the other hand, based
on Eq. 16, the noise in the reaction controlled regime should vary in proportion to the
cellular heterogeneity in n when km >> Cb. This result suggests that the cellular noise in
particle uptake may provide insights into the diffusion barrier of the extracellular medium.
From such noise, it may be possible to infer if particle uptake occurred in a reaction- or
diffusion-controlled condition.
3.5. CORRELATING CELL-SURFACE TRANSPORTER DENSITY WITH CELL
SIZE
In the previous analyses, we assumed that the cell-surface transporter density is
uncorrelated to cell size. As a result, the mean number of transporter per cell (4pir20 n˜) was
directly proportional to the cell surface area (r20 ). Here, n˜ refers to the mean transporter
density excluding the stochastic noise (σ2t = 0). However, it is possible that n˜ varies with
r0 due to the following reasons. A growing cell may try to maintain the same rate of uptake
per unit of mass (volume). Therefore, the uptake rate per unit area of the plasma membrane
of a growing cell may increase in proportion to r30 . Thus, for two cells of radius r0,1 and
r0,2, r20,1n˜1/r30,1 = r20,2n˜2/r30,2, i.e., n˜ ∼ r0. On the other hand, a counter-argument may be
that n˜ decreases with cell size, i.e., the two are anti-correlated. The rationale is that the
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Figure 6. Noise characteristics in the diffusion limit. The curves (and their colors) in each
panel correspond to those in Figure 5B except that the value of the parameter k f is (A) 10
times and (B) 100 times higher than the nominal value (Table 1).
transcriptional output of a growing cell may not be able to cope up with the growing mass
(r30 ) of the cell. Thus, such anti-correlation may actually contain a cell from an abnormally
high growth. A third possibility may be that the amount of transporter per cell (4pir20 n˜) has
nothing to do with cell size and all cells on average express the same number of transporter
molecules (except for the stochastic variations). This leads to 4pir20,1n˜1 = 4pir
2
0,2n˜2, i.e.,
n˜ ∼ r−20 .
To study the above possibilities, we consider n˜ = 〈n〉(r0/〈r〉0)α, as noted in the
model description. Here, α = 0 refers to the nominal case (Figure 5 and Figure 6). In
Figure 7, we show several hypothetical cases where α takes different positive and negative









whereas particle uptake rate in the diffusion-limited condition is
Ûm ≈ 4pir0DKmC∗b(1 − ψ) = 4pir0DKmC∗b(1 − DKmk−11 〈n〉−1〈r0〉αr−1−α0 ). (19)
As seen in the figure, in the positive range of α, the effect of this parameter becomes
apparent at α > 1, where uptake increases sharply with cell size under reaction control. In
contrast, in the negative range of α, it’s effect becomes apparent at α < −1.
Figure 7. Predicted correlation between cell size and particle uptake when cell-surface
transporter density is a function of cell size. The mean transporter density (n˜) varies with
cell size according to n˜ = 〈n〉(r0/〈r0〉)α. The top and bottom panels correspond to positive
and negative values of α, respectively, as indicated. Each color represents a distinct particle
diffusivity, as in Figure 5.
Notice that, our earlier analysis with α = 0 (Figure 5) indicated a nonlinear corre-
lation between cell size and particle uptake rate ( Ûm ∼ r20 ) in the reaction-limited regime.
However, Figure 7 suggests that a linear correlation in this regime is possible as well if α
is negative and close to -1. The model predicts that the correlation between cell size and
uptake is lost when α ≈ −2. Again, at α = −5, the model predicts an optimal cell size for
which particle uptake is maximum.
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3.6. EXPERIMENT VS. MODEL PREDICTIONS
We took four sets of fluorescent nanoparticles of mean diameter 26, 47, 100, and 200
nm, respectively, and analyzed their uptake in MDA-MB 231 cells using the above reaction-
diffusionmodel. Figure 8 shows the fit between the experimental data andmodel predictions
for the four different nanoparticle sizes. The model was used to make predictions on particle
uptake against each of the measured (estimated) cell sizes. The predicted particle uptake
values were scaled and fitted to the observed (normalized) fluorescence. Fitting was done
to capture the following observations: 1) cell size-dependent particle uptake and associated
noise (upper panels in Figure 8), and 2) cellular distribution of particle uptake (lower panels
in Figure 8). The figure shows good agreements between the experiments and the model.
The model parameter values obtained from these fittings are listed in Table 2.
The data for all four particle types reveals significant noise, indicating uptake occurs
in the reaction-limited regime in the cell culture medium. However, a linear dependency
between cell size and the internalized amount of nanoparticles is seen for all four particles,
thus contradicting the expectation that uptake in the reaction-limited regime should vary in
proportion to r20 (Figure 5). Note that, in Figure 7, the model predicted a linear relationship
between cell size and particle uptake is possible in the reaction-limited regime ifα is negative
and falls within a certain range. Our fitting led to α between −0.8 and −0.9 (Table 2). This
negative value indicates that the cell-surface density of the trafficking components (clathrin
pits or other structures) may actually decrease with the increasing size of an MDA-MB 231
cell.
From the fitting, we estimated transporter density, 〈n〉 = 0.946 µm−2 and its log-
normal variance σ2t = 0.071 − 0.116 (Table 2). Therefore, a typical MDA-MB 231 cell of
radius 8 µm is expected to have 760 transporter molecules in the plasma membrane. As
explained before, in our model, a transporter molecule is a hypothetical unit that processes
only one particle at a time. Reportedly, clathrin-coated pits play the key role in the uptake
of nanoparticles smaller than a few hundred nanometers in size (28). Thus, ignoring other
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Figure 8. Nanoparticle uptake by MDA-MB 231 cells. The top panels (scatter plots) show
single-cell fluorescence of internalized nanoparticles (black) for four different nanoparticle
sizes (diameters): (A) 26 nm, (B) 47 nm, (C) 100 nm, and (D) 200 nm. In the panels, black
and red points represent experimental data and model prediction (after fitting), respectively.
The solid lines represent the deterministic predictions (σt = 0). The experimental data
(fluorescence of cell-internalized particles) is presented after normalizing with a bead
fluorescence. The model predictions are scaled with a constant value (free parameter)
to fit the normalized fluorescence data. The lower panels (histograms) show the cellular
distribution of particle uptake for the four particle sizes. In each panel, black, red, and green
refer to the internalized particle fluorescence, the model predicted uptake, and control cell
fluorescence, respectively.
endocytic pathways and assuming 50 - 150 coated pits per cell (30), an average pit may
represent 4 − 15 transporters molecules. This implies each pit on average may handle
maximum 4 − 15 nanoparticles at a time. However, this could be an overestimate given
other endocytic pathways may contribute as well. Regardless, our analysis indicates that
the endocytic components of an MDA-MB 231 cell can easily be saturated at high enough
nanoparticle concentration in the solution, thus leading to a reaction-limited condition.
We held k1 and kr fixed at their nominal values (Table 2) because these two param-
eters are supposed to be cellular properties and hence independent of the size of a particle.
However, the fitting led to different values for the parameter K f depending on the particle
size (Table 2). This parameter defines the intrinsic rate of particle capture at the cell plasma
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Table 2. Parameter values estimated by fitting the model to theMDA-MB 231 cell data. The
bold-font indicates the values obtained from the fitting. The regular font indicates values
that were held fixed. The diffusion constants for different particle sizes were estimated
from Einstein-Stokes equation. Parameter n0 was constrained to have the same value for all
particle sizes.
Particle size (diameter)
Parameter 26 nm 47 nm 100 nm 200 nm
〈n〉 (µm−2) 0.946 0.946 0.946 0.946
σ2t 0.099 0.071 0.077 0.116
α -0.878 -0.792 -0.896 -0.811
k f (µm3s−1) 0.495 0.079 0.160 0.269
kr (s−1) 0.1 0.1 0.1 0.1
k1 (s−1) 0.02 0.02 0.02 0.02
D (µm2/s) 16.80 9.29 4.29 2.18
membrane. As seen in Table 2, for the two intermediate particle sizes (47 and 100 nm),
k f is relatively small. Given different endocytic pathways preferentially mediate uptake
for different cargo sizes, it is not surprising that this parameter varies with particle size.
However, a conclusive remark on this variation may require an investigation of particle
size-specific involvement of different endocytic pathways.
Note that a slight difference could be seen between our model and the flow cytometer
data in Figure 8. The data reveals considerably larger uptake in a small fraction of cells
that fall outside the range of the theoretical values, as evident in the scatter plots. This
little discrepancy could also be seen in the lower panels, where the experimental peaks are
little more stretched to the right compared to the theoretical peaks. It is possible that some
unknown factors make a small subpopulation significantly more capable. Nevertheless, the
model does not incorporate a mechanism to account for these outliers and has limited ability
to explain this small discrepancy.
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4. DISCUSSION
In this work, we provided a detailed analysis of nanoparticle uptake at the single-
cell level. In our analysis, we mainly focused on two cellular attributes that may jointly
determine particle uptake: 1) cell size (r0), and 2) membrane expression (density) of
transporter molecules (n). We have shown that a simple scatter plot (Figure 2) can dissect
cellular heterogeneity in particle uptake arising from the joint contributions of these two
attributes of a cell. The plot itself reveals how uptake varies with cell size. On the other
hand, the noise in the plot reveals cell-to-cell variability in n. Importantly, the noise, even
though originates from n, is tightly coupled to the diffusion barrier of the extracellular
medium (Figure 6). We postulate that such noise in a flow cytometer data may provide
information about the level of the transport barrier in the extracellular medium.
Our study shows no noticeable transport effect on particle uptake in a cell culture
medium with water-like viscosity. However, in a in vivo tissue or tumor, the transport
effect may be significant. The uptake of nanoparticles by a target (cancer) cell in the
tumor interstitial matrix may be governed by the poor effective diffusion in the presence of
the non-specific cells, the dense network of collagen fibers, and other biological barriers
(31; 32; 33). In addition, the physiological concentration of nanoparticles in a tissue or
tumor could be very small (34), which may also lead to transport-controlled uptake.
Using flow cytometer FSC, we have characterized MDA-MB 231 cell size distribu-
tion, which was further confirmed by analyzing microscopy images. The general notion is
that FSC-A may provide an unreliable estimate of cell sizes because the measurement can
be influenced by the refractive index of the fluid, intracellular light-absorbing structures,
and the design of the FSC-measurement device itself (35; 36). Our analysis shows that FSC
provides a slight overestimate of cell size but it can be pretty accurate in estimating the cell
size distribution. Simply a shift the FSC-based cell size distribution showed an excellent
agreement with the actual cell size distribution obtained from microscopy image analysis
(fig 1).
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By fitting our model flow cytometer data, we obtained an accurate agreement be-
tween the model predictions and the measured particle uptake in MDA-MB 231 cells. Our
measurement revealed significant noise in uptake (Figure 7). The data indicated almost a
linear increase in the uptake rate with increase in the cell size (radius). Our model-based
analysis of the experimental data suggests that the number of transporter molecules per unit
cell membrane may decrease with an increase in the cell size. This phenomenon may be
a defining characteristic of cell growth. Cells above a certain size may struggle to main-
tain uptake through the plasma membrane in proportion to their mass (r30 ) and this might
manifest itself in a reduction in transporter density (7; 8; 9).
In a recent work, Wang et al. (14) reported several findings that are consistent with
our experimental data and analysis. The authors reported an approximately liner correlation
between nanoparticle uptake and cell radius (Figure 7B and 7C in (14)). In the study, human
mesenchymal stem cells (hMSCs) were cultured on micropatterened surfaces. The growth
(size) of the cells were controlled by the patterns of the surfaces. Consistent with our work,
the study also reported that larger cells displayed a reduced level of particle uptake per
unit area of the plasma membrane. This observation was attributed to the difference in
the stiffness of the cells. The study showed that the larger cells were more stiff compared
to their smaller counterparts. Nevertheless, a direct evidence was not established that the
stiffness was indeed the reason behind the cell-size dependent difference in the particle
flux across the cell membrane. Our work therefore provides a new perspective to these
observations that can be explained from a different angle. A larger micropatterned cell with
an increased surface area may imply a reduced number of transporter molecules per unit
area of the plasma membrane. Therefore, the decrease in particle flux may reflect a reduced
endocytic activity per unit area of a larger cell. It should be noted that, in our experiments,
all cells were grown in a common identical environment (cell culture medium) unlike in
(14), where micropatterened surfaces were used to direct the cell growth. Our cell sizes
therefore reflect the natural heterogeneity in cell growth under a common growth medium.
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Therefore, although our observations are similar, unlike the micropatterened cells in (14),
the uptake behaviors of our cells may not be attributable to their differential stiffness. It
would be, however, interesting to investigate whether the naturally grown cells also display
similar size-dependent stiffness like the micropatterned cells reported in (14).
Although it was not our focus to study the physicochemical attributes of nanopar-
ticles, our experiments with MDA-MB 231 cells involved nanoparticles of four different
sizes (Figure 8). Our interest in this case was to see if the uptake characteristics could vary
based on the size of the particles. Our data revealed no significant qualitative differences
among the particles. For all four particle sizes, our experimental data revealed nearly linear
correlation between cell size and the amount of particle uptake. The model was also able to
accurately the describe the uptake data associated with all four particles. However, from the
fitting, the intrinsic rate of particle capture (k f ) appeared to be different depending on the
particle size. This could be due to the fact that particles of different sizes are differentially
handled by the endocytic pathways.
Particle uptake at the cellular level governed by many factors associated with the
highly complex endocytic and intracellular trafficking pathways as reviewed in (26). In
addition, the diffusion of the transporter molecule or particle-specific receptor proteins
in the plasma membrane can influence particle uptake (37). However, in the absence
of cell type-specific quantitative information, incorporation of such details entails more
parameters and associated uncertainties in a model. Therefore, the net contributions from
these individual factors are often homogenized into an effective rate of uptake and the entire
uptake process can be simplified into a reaction-diffusion problem (27; 34; 38; 40; 41; 42).
In our study, we also ignored the individual factors that associated with distinct pathways.
Instead, we divided the uptake process into two steps. The fist step is associated with
the diffusion of particles through the external medium. And the second step is particle
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interaction uptake by a generic transporter molecule in the cell membrane. Incorporation of
the detailed molecular mechanisms and individual factors associated with various endocytic
mechanisms is beyond the scope this study.
It should be noted that our model ignores convective transport of nanoparticles. We
consider pure diffusion in our system, which is typical for a cell culture medium. Also, in
the dense interstitial matrix of a tumor, convection is usually poor while diffusion serves as
the dominant transport mechanism (33). The single-cell nanoparticle uptake characteristics
can be more complex in the presence of an advective transport in a biological tissue. Amore
complex model and experimental investigation are necessary to determine how reaction,
diffusion, and advection together may determine cell-size dependent nanoparticle uptake in
in vivo tissue conditions.
An interesting extension of our study might be to investigate whether the uptake
of other external resources, including various nutrients, follow similar behavior described
in this study. One of the core findings of this work that the particle flux (uptake per unit
cell surface area) might decrease in a growing cell provides an interesting possibility. If
such behavior applies to some other molecules necessary for cell growth, it may work as a
feedback mechanism for limiting cell sizes in different growth environments, as depicted in
Figure 9
5. CONCLUSION
Our study emphasizes understanding cellular uptake processes at the single-cell
level. The analysis shows that the rate of nanoparticle uptake by single cells is tightly
coupled to the cell size as well as the transport barrier of the extracellular medium. Using
model predictions and quantitative single-cell analysis, we have shown how the extracellular
diffusion and cellular heterogeneities in cell size and endocytic capacities shape the overall
nanoparticle uptake behavior of single cells. Although the predictions and analyses provided
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Figure 9. A possible relationship between cellular uptake of external resources and cell
growth. Top: common perception about how cellular uptake might be related to cell size.
Bottom: a potential regulation of cell size by based on a growing cell’s ability to avail
external resource. An arrow represents a positive influence, and a blunt arrow indicates a
negative influence.
are in the context of nanoparticle uptake, it may be possible to extend the findings to
the cellular uptake of different nutrients and biomolecules as well. However, further
investigations are necessary to confirm such a hypothesis.
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ABSTRACT
The rule-based modeling approach provides a unique capability to model biochem-
ical network systems considering the site-specific details of the network species (protein
molecules and their complexes). However, a major bottleneck of the rule-based approach is
combinatorial complexity, which compromises its broader application. Combinatorial com-
plexity refers to a condition where a small set of molecules in a model gives rise to a large
number of network species due to the many possible combinations of site-specific assembly
and transformations of the molecules. Here, we introduce an approach to systematically
restructure a rule-based model and eliminate combinatorial complexity while avoiding any
loss of information or prediction accuracy. We demonstrate the general applicability of the
approach by creating detailed mechanistic models of the receptor tyrosine kinase (RTK)
systems. We identify five distinct mechanisms whereby the RTKs become activated in the
cell membrane. For each mechanism, we develop a rule-based model by incorporating com-
prehensive details of ligand-receptor binding, receptor phosphorylation, and recruitment of
downstream signaling proteins. By applying our approach, we restructure these models and
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provide analysis on their network dimension, computational performance, and accuracy
of prediction. Our work introduces an approach to create highly mechanistic biochemical
network models. By applying the approach to RTK signaling proteins, we demonstrate its
potential usefulness for modeling a larger number of cell signaling pathways.
Keywords: Model reduction, Cell signaling, Mechanistic modeling, Systems biology,
Combinatorial complexity
1. INTRODUCTION
In this work, we introduce a systematic approach to simplify large-scale biochemical
network models developed using the rule-based modeling approach (1; 2). The rule-based
approach provides an advanced capability to build biochemical network models by incorpo-
rating the coarse-grained details of the network species (protein molecules or complexes).
This feature is particularly useful for modeling cell signal transduction pathways, where the
protein molecules have modular structures containing submolecular components, such as
functional domains and phosphorylation motifs (3; 4). Nevertheless, a major bottleneck for
the rule-based approach is combinatorial complexity (5), which refers to a condition where
only a fewmolecules in amodel give rise to a large number of network species throughmany
possible combinations of site-specific assembly or transformations. Such property severely
compromises the scope of the rule-based approach for modeling cell signal transduction
pathways. Numerical simulation of a rule-based model consisting of only a few signaling
protein molecules often becomes computationally prohibitive or infeasible.
In this work, we introduce an approach to develop highly mechanistic rule-based
models by eliminating the combinatorial complexity of protein-protein interaction. In
the rule-based approach, network species (molecules and complexes) are represented by
graphs, while their interactions and biochemical transformations are defined by graph-
rewriting rules (2; 6). We show that systematic steps can be followed to restructure these
graphs and graph-rewriting rules to avoid combinatorial complexity while keeping the re-
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structured model identical to the natural form in capturing the biological details. Unlike
the typical model reduction (7), this simplification entails no loss of information or predic-
tion accuracy and requires no trade-off consideration between the complexity of a model
and its mechanistic abstraction. We demonstrate the general applicability of the model
restructuring approach by developing highly mechanistic rule-based models of the receptor
tyrosine kinase (RTK) systems (8). The RTKs represent a broad class of transmembrane
receptor proteins that are critical mediators of several signaling pathways regulating cell
death, growth, differentiation, and migration (9). The RTK systems are particularly chal-
lenging to model using the rule-based approach because of the high degree of combinatorial
complexity arising from their modular domain structures, numerous autophosphorylation
sites (tyrosine motifs), and interaction with downstream effector proteins (10). A common
feature of the RTKs is that they contain an intrinsic kinase domain in their cytosolic tail.
When crosslinked by an extracellular ligand, the kinase domain of the crosslinked recep-
tors become activated and autophosphorylate tyrosine motifs in the cytosolic tails. The
autophosphorylated tyrosines then recruit a variety of signaling proteins via non-covalent
binding interactions. These recruited proteins activate other downstream protein molecules
associated with different signaling pathways. We found that the majority of the RTK pro-
teins can be divided into five distinct groups based on the mechanism of activation in the cell
plasma membrane. For each of these five mechanisms, we created a model using the rule-
based model specification language BNGL (2). The models incorporated comprehensive
site-specific details associated with ligand binding, autophosphorylation, and recruitment of
the downstream proteins. We then restructured each of these models by applying our model
restructuring approach and analyzed these restructured models for their network dimension,
computational gain, and prediction accuracy against the natural (unstructured) models. Our
analysis shows that highly mechanistic but computationally-efficient models are possible
without incurring any loss in the prediction accuracy. Because many receptor proteins also
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follow the samemechanisms of activation of the RTK proteins, the restructuring approaches




Themodelswere created using the rule-basedmodel specification languageBNGL (2).
Several rule-based modeling software, which includes BioNetGen (2; 6), NFsim (11), and
RuleMonkey (12), are capable of executing BNGL models. Each model was created in its
natural form and restructured form. The natural form refers to a typical formulation of a
rule-based model, where the molecules and rules are defined based on the way those occur
naturally. The restructured form refers to the model where we apply our method to redefine
the molecules and rules to avoid combinatorial complexity. The BNGL files associated with
each model in the natural and restructured forms are provided in Supplementary File 1.
2.2. SIMULATION
Simulations were performed using rule-based modeling software BioNetGen (2; 6)
or NFsim (11). NFsim was used in special cases where BioNetGen was unable to execute a
model due to the large network size. BioNetGen internally translates aBNGL-specified rule-
based model into an ordinary differential equation (ODE) model, which is then numerically
integrated using CVODE (13). NFsim implements a specialized stochastic simulation
algorithm, called network-free KineticMonte Carlo, that generates the species and reactions
on-the-fly during the course of a simulation (14).
110
3. RESULTS
Below, themodel restructuring approach is explained using a simple examplemodel.
Its application to modeling the RTK signaling systems is discussed next.
3.1. A SIMPLE RULE-BASED MODEL
We consider a simple receptor activation model, which is illustrated in Figure 1. The
model consists of a bivalent ligand and a monovalent transmembrane receptor molecule.
The ligand mediates receptor crosslinking and dimerization via binding to the extracellular
domain of the receptors. The crosslinked receptors, which are assumed kinase activated,
transphosphorylate the tyrosine residues in their cytosolic tails. In this example, we consider
only two tyrosine per receptor (Figure 1) although The number could vary between 6 − 10
in different RTKs.
Figure 1. A simple model. A transmembrane receptor R recruits a bivalent ligand molecule
L from the extracellular space (solution) and forms a 1:1 ligand-receptor complex (L.R).
The ligand molecule then mediates receptor crosslinking to form a receptor dimer (a 1:2
ligand-receptor complex L.R.R). Subsequently, the crosslinked (activated) receptors are
autophosphorylated in their the tyrosine residues. Tyrosine dephosphorylation occurs in a
first-order process.
It is straightforward to define the above molecules and interactions using a rule-
based model specification language, such as BNGL. A comprehensive overview of BNGL
notations and syntaxes are available in (2). However, for completeness, we briefly explain
the notations here that are essential to describe the model. Let us denote the ligand molecule
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as L(r, r), where L is the name of the molecule and r is its receptor binding site. There are
two identical receptor binding sites in the molecule. Let us denote the receptor molecule
as R(l, y1 ∼ u ∼ p, y2 ∼ u ∼ p), where R is the molecule name, l is the extracellular
domain for ligand binding, and y1 and y2 are the two distinct autophosphorylation sites.
Each autophosphorylation site is allowed to be in two internal states: unphosphorylated
(∼ u) and phosphorylated (∼ p). With these notations, a set of BNGL rules can specify the
site-specific binding, dissociation, phosphorylation, and dephosphorylating reactions. The
first rule below describes ligand recruitment to form a 1:1 ligand-receptor complex (L.R).
The second rule describes corresponding reverse reaction, i.e., dissociation of the ligand
into the solution.
R(l) + L(r, r) → R(l!1).L(r!1, r) k f
R(l!1).L(r!1, r) → R(l) + L(r, r) kr
The symbol “!” followed by a matching number (in this case 1) indicates a bond linking
the ligand and receptor sites that hold the two molecules together in the complex. The
rate parameters associated with the rules are denoted by k f and kr , respectively. In the
rules, the phosphorylation states are not specified explicitly assuming ligand binding is
independent of receptor phosphorylation. The following two rules respectively describe
receptor crosslinking to form the receptor dimer (Figure 1), and corresponding dissociation
reactions.
R(l) + L(r!+, r) → R(l!1).L(r!+, r!1) kx
R(l!1).L(r!+, r!1) → R(l) + L(r!+, r) kr
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In the first rule, the !+ sign followed by r indicates that this receptor binding site in the ligand
molecule is connected to a receptor via a bond (i.e., it implicitly refers to the 1:1 complex
L.R). The right-hand side of the rule describes the receptor dimer (1:2 ligand-receptor
complex, L.R.R). The rate constants associated with the reactions are denoted by kx and
kr , respectively.
The following rules describe tyrosine phosphorylation and dephosphorylation both
modeled as first-order processes. For each phosphorylation site, a distinct rule is specified.
These rules allow only receptors in their crosslinked states to be phosphorylated.
R(l!+).R(l!+, y1 ∼ u) → R(l!+).R(l!+, y1 ∼ p) kp1
R(l!+).R(l!+, y2 ∼ u) → R(l!+).R(l!+, y2 ∼ p) kp2
R(l!+).R(l!+, y1 ∼ p) → R(l!+).R(l!+, y1 ∼ u) dp1
R(l!+).R(l!+, y2 ∼ p) → R(l!+).R(l!+, y2 ∼ u) dp2
3.2. RESTRUCTURED MODEL
Figure 2 illustrates the method we apply to restructure the simple model described
above. As a first step of the restructuring process, we represent the molecules in more
compact notations by lumping their identical or redundant components (binding domains
or motifs). In our example, the ligand molecule contains two identical receptor binding
sites. We remove these two components and consider a single binding surface for a receptor
(Figure 2A).
As a second step, which is the key to eliminating combinatorial complexity, we
restructure the receptor molecule by representing it as a set of smaller molecules each
of which corresponds to one small part of the original molecule (Figure 2A). Each new
molecule in the set contains an extracellular ligand binding domain s (similar to l in the actual
113
Figure 2. Illustration of the restructured model. (A) Restructured representations of
the ligand and receptor molecules. (B) Restructured representations of the molecular
interactions and transformations.
receptor notation) but represents only one autophosphorylation site. The BNGL notations
for these molecules are R1(s ∼ 0 ∼ 1 ∼ 2, y1 ∼ u ∼ p) and R2(s ∼ 0 ∼ 1 ∼ 2, y2 ∼ u ∼ p)
(Figure 2A).
We consider three possible internal states for s: s∼0, s∼1, and s∼2 (Figure 2B). These
states implicitly refer to a ligand-free receptor, a ligand-bound but uncrosslinked receptor
(corresponding to a receptor the 1:1 complex of the original model), and a receptor in a
crosslinked state (receptor dimer), respectively, as illustrated in Figure 2B. These alternative
notations for s avoid explicit ligand-receptor binding and crosslinking (formation of L.R or
L.R.R) in the model. Finally, we introduce two separate (but identical) ligand molecules
L1 and L2 specific to R1 and R2, respectively (Figure 2B). Both these ligand molecules are
assigned a copy number identical to that of L in the original model. Similarly, both R1 and
R2 are also assigned a copy number identical to that of the original receptor protein.
With the above new molecule notations, the BNGL rules can be restructured and
the parameter values can be scaled such that the kinetic and steady-state behaviors remain
identical to the natural model. The following set of rules describes ligand recruitment and
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dissociation for R1 and R2.
R1(s ∼ 0) + L1→ R1(s ∼ 1) 2k f
R1(s ∼ 1) → R1(s ∼ 0) kr
R2(s ∼ 0) + L2→ R2(s ∼ 1) 2k f
R2(s ∼ 1) → R2(s ∼ 0) kr
Note that the forward rate constant k f is scaled by a factor of 2. This is because the
restructured ligand molecule has only one receptor binding site, whereas the original ligand
contained two identical receptor binding sites.
The following set of rules implicitly describes receptor crosslinking and dissociation
in the membrane. Unlike the original model, the crosslinked state of the receptor is defined
by the by changing the internal state of s, as explained earlier.
R1(s ∼ 1) + R1(s ∼ 0) → R1(s ∼ 2) kx
R2(s ∼ 1) + R2(s ∼ 0) → R2(s ∼ 2) kx
R1(s ∼ 2) → R1(s ∼ 1) kr
R1(s ∼ 2) → R1(s ∼ 0) kr
R2(s ∼ 2) → R2(s ∼ 1) kr
R2(s ∼ 2) → R2(s ∼ 0) kr
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The following set of rules describe phosphorylation and dephosphorylation of R1 and R2.
R1(Y1 ∼ u) → R1(s ∼ p) kp1
R1(Y1 ∼ p) → R1(s ∼ u) dp1
R2(Y2 ∼ u) → R2(s ∼ p) kp2
R2(Y2 ∼ p) → R2(s ∼ u) dp2
3.3. NETWORKSIZECOMPARISON:NATURALVS.RESTRUCTUREDMODEL
From the above restructuring, the combinatorial complexity is eliminated due be-
cause the new rules 1) avoid explicit receptor crosslinking or formation of L.R.R; and 2)
eliminates the possibility of many possible combinations of phosphorylation states of the re-
ceptor by distributing its tyrosine sites into a collection ofmolecules. Note that, in the natural
model, the receptor contains two phosphorylation sites each of which can be in the phospho-
rylated or unphosphorylated state. Thus, a receptor can assume four possible combinations
of phosphorylation states. On the other hand, the receptor dimer L.R.R can take 10 possible
phosphorylation states excluding degeneracy. Thus, considering L, R, L.R, and L.R.R, the
reaction network contains 19 distinct species. In contrast, in the restructured model, con-
sidering L1, L2, R1(s 0), R1(s 1), R1(s 2), R2(s 0), R2(s 1), R2(s 2), and the two possible
phosphorylation states per receptor, only 14 distinct species are possible. Certainly, this is a
small difference in the network size between the natural and the restructured form. However,
this difference increases dramatically with an increase in the number of autophosphorylation
sites per receptor. Let us consider a general case where the receptor protein contains an arbi-
trary n autophosphorylation sites (instead of only two in the above example). Now, in the nat-
uralmodel, each receptorwill take 2n phosphorylation states. On the other hand, each L.R.R,





nCinCj + (1/2)∑ni=0 nCi(nCi + 1)
phosphorylation states. Thus, including the ligand molecule and all possible receptor phos-
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phorylation states, the total number of species in the natural model can be enumerated:





nCinCj + (1/2)∑ni=0 nCi(nCi + 1). If n = 2, the number of species,
1+23+[2C02C1+2C02C2+2C12C2+2C0(2C0 + 1)/2+2C1(2C1 + 1)/2+2C2(2C2 + 1)/2] = 19,
for example. In contrast, the restructured model contains only 7n species representing the
n distinct ligand molecules, n distinct receptor molecules, 3n distinct ligand binding states
(s ∼ 0, s 1, and s 2) per receptor molecule, and 2 phosphorylation states per receptor
molecule. Table 1 compares the natural and restructured model network dimensions for
n = 1 − 10.
Table 1. Network size comparison between the natural and restructured model.
Phosphorylation
sites, n (#/receptor)
Natural model Restructured model
Species (#)1 Reactions (#)2 Species (#)3 Reactions (#)2
0 4 4 4 4
1 8 16 7 16
2 19 72 14 32
3 53 336 21 48
4 169 1,568 28 64
5 593 7,232 35 80
6 2,209 32,896 42 96
7 8,513 147,712 49 112
8 33,409 655,872 56 128
9 132,353 ∞ 63 144
10 526,849 ∞ 70 160





nCinCj + (1/2)∑ni=0 nCi(nCi + 1)
2 Generated using BioNetGen
3 Number of species is 4 if n = 0 and 7n if n > 0.
In Figure 3, we show how the computation time changes in the natural and the
restructured model with an increase of n. The figure is generated by running the models
in BioNetGen. BioNetGen executes a model two steps. In the first step, it generates the
reaction network, i.e., it translates the BNGL rules into a system of ODEs, which describe
the time evolution of the network species. In the second step, it performs simulation, i.e.,
numerically integrates the ODEs for a prescribed period of time. In Figure 3A, the time
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required to complete the first step (network generation) is reported. The result indicates the
network generation time is ∼ 10n in the natural model, whereas, in the restructured model,
it remains constant for the entire range of n. Figure 3B shows time needed to complete the
second step (simulation or integration of the ODEs) in the natural model. There is a steep
increase in computation time at n > 3. In contrast, in the restructured model, simulation
time was close to zero for n = 1 − 10 (not shown in the figure).
Figure 3. BioNetGen network generation and simulation time comparison between the
natural and restructured formulation. (A) Reaction network generation time (CPU time) in
BioNetGen as a function of the number of phosphorylation sites (n). The black and red
correspond to the natural formulation and reduced formulation, respectively. (B) Simulation
completion times in BioNetGen. For each n, the model was simulated for 3,600 seconds
and corresponding simulation completion time (CPU time) was recorded. The black dots
represent the natural formulation. The simulation time for the restructured model was close
to zero for all n and not shown in the figure.
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3.4. MODELING THE RTK SIGNALING SYSTEMS
The simple example model described above, in fact, represents the activation pro-
cess of several RTK proteins, which include KIT (15), VEGFR2 (16), and NRTK1 (17).
However, the exact restructuring process detailed for this model cannot be generalized.
Restructuring different RTK proteins may require different considerations based on their
molecular structures and interaction with the activating ligand. The remaining steps for
receptor phosphorylation and dephosphorylation could be treated as generic if modeled as
simple first-order processes. We found that majority of the RTKs follow only five distinct
mechanisms of ligand-mediated crosslinking and activation. Therefore, only five models
may describe the activation process of a large number of RTK proteins.
3.4.1. Classification of RTKs Based on Ligand-Receptor Interaction. Figure 4
illustrates the five distinct mechanisms of RTK activation based on which we categorized
the proteins into five different groups.
Figure 4. Classification of RTK activation mechanisms based on the receptor-ligand
interaction. Type I (KIT-SCF, VEGFR2-VEGFA, NRTK1-NGF), Type II (EGFR-EGF,
NRG1-ERB4). Type III (RET-ARTN-GFR3), Type IV (FGFR1-FGF2-HSPG), Type V
(IGF1R-IGF1, INSR-INS).
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In the figure, Type I represents the example model, i.e., the common mechanism of
activation of KIT, VEGFR2, and NRTK1. Type II represents activation of EGFR (18) and
NRG1 (19) by ligands EGF and ERB4, respectively. In Type II, ligand binding induces a
conformational change in the intracellular tail of the receptor. This conformational change
enables the receptors to form a dimeric complex wherein the receptors transphosphorylate
their tyrosine sites via their kinase domains. Type III represents activation of RET by two
different ligands, ARTN or GFR3 (20). However, activation of this type also requires a
transmembrane cofactor protein in addition to the ligand. In fact, the cofactor protein first
recruits a ligand and subsequently mediates receptor crosslinking in a mechanism similar
two Type I. Type IV corresponds to activation of FGFR2, which also requires two ligands,
FGF2 and HSPG (21; 22). Similar to Type III, it requires a cofactor protein, which first
recruits either of these two ligands. The cofactor then mediates FGFR2 dimerization in a
manner similar to Type II. Type V represents activation of IGF1R (23) and INSR (24) via
ligands IGF1 and INS, respectively. In this type, the receptors exist as preformed dimers.
Recruitment of a ligand in these dimers induces a conformation change in the receptor
cytosolic tail, which activates the receptors.
3.4.2. RTK Models: Natural vs. Restructured Forms. We took one representa-
tive RTK protein from each of the five groups and created a BNGL model for the protein
in the natural and restructured form (Supplementary File 1). The five RTK proteins, which
were modeled, are listed in Table 2. In the models, we incorporated the receptor-specific
autophosphorylation sites (Table 2) and their interaction with a variety of downstream sig-
naling proteins. We provide a full list of these receptor-specific signaling proteins and their
phosphorylation site-specific binding specificity (equilibrium dissociation constant KD or
binding affinity) in Supplementary Table 1. In Table 2, we compare the network sizes of
a truncated version of the five RTK models in their natural and restructured forms. These
truncated models incorporate the events up to receptor phosphorylation but exclude recruit-
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ment of the downstream signaling proteins. It was not possible to compare the full model
network sizes because the network sizes of the models were too large to be computed using
BioNetGen.
In Figure 5, we compare the computational efficiency of the full models in their
natural and restructured forms. Because BioNetGen was unable to handle the full models,
we simulated themusingNFsim. All corresponding restructured formswere simulated using
BioNetGen. The result indicates a few orders of magnitude difference in the computation
speed between the two forms. The inefficiency of the NFsim simulations is expected
because the software implements stochastic simulation, which is computationally expensive
compared to the simulation of an ODE model.
Table 2. Network size of different RTK models.
RTK (type) Phosphorylation
sites (#/receptor)
Natural form Restructured form
Species (#) Reactions (#) Species (#) Reactions (#)
KIT (Type I) 10 (25; 26; 27; 28; 29) ∞1 ∞1 70 160
EGFR (Type II) 7 (30; 31; 32; 33; 34; 35) 8,513 132,352 7 91
RET (Type III) 9 (36; 37; 38; 39; 40) 132,867 2,892,546 108 225
FGFR2 (Type IV) 6 (41; 42; 43) 2,211 29,250 54 90
IGF1R (Type V) 6 (30; 44; 45; 46) 8,257 90,112 30 42
1 BioNetGen was unable to compute the network size.
Figure 5. RTK model execution times in their natural and restructured form. The X-axis
refers to the five RTK models, each of which is named after the RTK protein. The Y-
axis represents corresponding model execution times (CPU seconds). The black and red
respectively correspond to the natural model and restructured model, which were executed
using NFsim (stochastic simulation) and BioNetGen (deterministic simulation). All models
were simulated for 3,600 seconds.
121
To demonstrate that the natural and restructured models are identical, we compare
several simulation results (readouts) in Figure 6. The results clearly indicate an accurate
agreement between these two forms of the models. In Figure 6A, the readout is IGF1R
phosphorylation at Y980 in response to IGF1. In Figure 6B, the readouts are the recruitment
of three signaling proteins in IGF1R in response to IGF1. These signaling proteins are the
src homology 2 domain-containing transforming protein C1 (SHC1), the RAS p21 protein
activator 1 (RASA1), and phospholipase C gamma 2 (PLCG2). As listed in Table S1, these
proteins are recruited via several IGF1R phosphorylation sites with distinct binding affinities
(Table S1). SHC1 is recruited by phosphorylated Y980 (pY980), RASA is recruited by
both pY1161 and pY1346, and PLCG1 is recruited by both pY1166 and pY1346. Thus,
the result in Figure 6B also indicates an agreement between the natural and restructured
models in predicting phosphorylation of the above tyrosine sites. Figure 6C compares KIT
autophosphorylation at Y900 in the natural and restructured model. Figure 6D compares
recruitment of SHC1, RASA, and PLCG1 in KIT. SHC1 is recruited by pY553, pY900,
and pY936, RASA1 is recruited by pY553 and pY900, and PLCG1 is recruited by pY570,
pY721, and pY900 in KIT.
4. DISCUSSION
Understanding the complex phenomena underlying biochemical and biological sys-
tems requires large-scale mechanistic models. Over the years, advanced modeling ap-
proaches and algorithms have been developed to account for the greater degree of biological
complexity in a model. The rule-based modeling approach is at the forefront of these tech-
niques. Theoretically, a rule-based model can describe a biochemical network system with
arbitrary levels of complexity and molecular-scale details. However, the limiting factor is
often the computational burden associated with the numerical simulation of these models,
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Figure 6. Comparison of predictions of the natural and restructured RTK models. In each
panel, the open circles and solid line represent the natural model (NFsim simulation) and
restructured model (BioNetGen simulation), respectively. (A) Predicted IGF1R phospho-
rylation at Y980. (B) Predicted IGF1R recruitment of signaling proteins SHC1 (black
circle/red line), RASA1 (green circle/black line), and PLCG2 (blue circle/magenta line).
(C) Predicted KIT phosphorylation at Y900. (D) Predicted KIT recruitment of SHC1 (black
circle/red line), RASA1 (green circle/black line) and PLCG2 (blue circle/magenta line).
as explained in the paper. The model restructuring approach introduced in this work creates
an opportunity to capture unprecedented levels of biological complexity in the rule-based
models.
We have provided several nontrivial demonstrations our model restructuring ap-
proach in the context of five specific RTK proteins. Each of these proteins corresponds to
a distinct activation mechanism that encompasses a large number of other RTK proteins.
Besides RTK signaling, the approach should be generally applicable to other cell signaling
systems. For example, many of the immunoreceptor systems are also activated following
similar mechanisms of ligand-receptor binding, receptor crosslinking, and tyrosine phos-
phorylation in the cell membrane (4; 47). The core principle, which reduces combinatorial
complexity through alternative notations of themolecules and complexes, should be applica-
ble for all such systems. Our approach might be particularly useful for modeling multivalent
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assembly of molecules in many natural and synthetic systems (48; 49; 50; 51; 52; 53). The-
oretically, two multivalent molecules can combine in stoichiometry and form polymeric
complexes of arbitrary chain or ring structures (53; 54). The assembly of two multivalent
molecules cannot be formulated into a typical differential equation model (55; 56). On
the other hand, the Gillespie’s stochastic simulation algorithm, which relies on network
generation, is also not applicable to such systems. This deficiency of the ODE models and
Gillespie’s method motivated the network-free stochastic simulation (14) and the NFsim
software (11). However, like Gillespie’s algorithm, the network-free simulation is com-
putationally inefficient (Figure 5), suffers from poor scalability issues and easily becomes
prohibitive for systems with large separation in the timescales. Recently, NFsim has been
used been used to develop a detailed model of epidermal growth factor receptor (EGFR)
signaling (10). The site-specific molecular details incorporated in this model are compa-
rable to the RTK models we present in this work. Nevertheless, the model was limited to
analyzing only short-time transient EGFR response behavior possibly due to the inefficient
computation.
The model restructuring approach may potentially enable highly mechanistic multi-
cellular modeling using the rule-based approach. The rule-based approach has traditionally
been used to model single-cell biochemical network systems. Nevertheless, a single-cell
model does not capture the cell-to-cell variability in response behavior arising from the
heterogeneity in biochemistry. To study the cell population response, a common practice
is to perform a large number of simulations on a single-cell model by initiating each sim-
ulation with a distinct set of cell-specific parameter values and conditions (57). However,
the computational cost associated with such repeated simulations limits the level of details
of the single-cell model. Recently, we have developed a highly mechanistic IGF1R signal-
ing model by applying our model restructuring approach (unpublished work). We used to
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this model to analyze cellular heterogeneity in IGF1R phosphorylation and recruitment of
signaling proteins. Without restructuring, it was impractical to perform even a single-cell
analysis using the model.
Parameter estimation for large-scale rule-based models remains to be a challenge.
A recently-developed software BioNetFit (58) is designed to enable systematic data fitting
and parameter estimation on BNGL-specified models. However, because the fitting routine
requires iterative simulation on a model, application of the software remains limited to
relatively simple deterministic models. The model restructuring approach may enable data
fitting and parameter estimation for mechanistic rule-based models.
5. CONCLUSIONS
This work demonstrates that a rule-based model can be systematically restructured
to greatly simplify the network dimension. The simplified model remains identical to
the original model in its predictive power and mechanistic abstraction. By applying the
approach, we have developed highly detailed models for a broad class of RTK signaling
proteins. The approach may serve as a tool to create biochemical network models capturing
unprecedented levels of biological details.
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2. CONCLUSIONS AND FUTUREWORKS
In this dissertation, I demonstrated the spatial modeling framework for multivalent
protein-protein interaction. The modeling framework is very useful for site specific ligand-
receptor aggregation, protein-protein interaction and lipid-raft interaction. The multiscale
framework includes time adaptive feature and spatial graphs which aids to capture site
specific interaction without any overlapping. I applied our framework for immunoreceptor
(FcεRI) aggregation in presence of trivalent antigen. I showed a detailed analysis of multi-
valent FcεRI (TLBR) aggregation along with membrane diffusion. This spatial modeling is
very handy for small scale mechanistic modeling, but it may be difficult for large scale bio-
chemical networks. However, complex cell signaling network can bemodeled by rule-based
modeling which is a nonspatial modeling tool(26; 27). However, one of the major challenge
of rule-basedmodeling is combinatorial complexity. I applied the restructuration techniques
in a rule-based model that will eliminate combinatorial complexity(28). The restructured
model is equivalent to the natural model without compromising accuracy. We implemented
this approaches for five different receptor tyrosine kinases (RTK) which has different acti-
vation mechanism in cell membrane(1; 29). The model restructuring approaches are very
useful to evaluate and understand the large biochemical networks. For this purpose, I am
extending our earlier published work(30) based insulin growth factor 1 (IGF1R) signaling
into autophagy regulation signaling pathways as shown in Fig. 2.1. In most cells, PI3K
protein plays a critical role in growth factor signaling pathways(31; 32; 33). Based on the
literature, PI3K protein binds with AKT and mTOR and forms PI3K-Akt-mTORC complex
which is responsible for autophagy signaling pathways(32; 34; 35; 36). In this work, I am
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going to apply the model restructuring approaches and investigate the insight of autophagy
regulation with influenza virus through mathematical modeling analysis and experimental
data from the literature(32; 37; 38).
Figure 2.1. Application of model restruration approaches to extend IGF1R model into a
model for interactions among PI3K, AKT, mTORC1, mTORC2, AMPK and ULK1. Figure
adapted from Subbiah et al.,PLoS One (2009)(31).
In our earlier published(39)and unpublished work, I also have studied the cellular
uptake behavior in single MDA-MB 231 cell by conducting both quantitative experimental
and modeling analysis. So far, I implemented steady state reaction-diffusion model for
nanoparticle uptake at the cellular level which can describe the important factors such as
extracellular diffusion, endocytic properties, complex exocytosis, particle internalization
process, cell type and so on(40; 41; 42). I also have formulated the kinetic model of particle
133
uptake in a single cell which captures cell size and endocytic properties in the plasma
membrane. To extend this work, currently, I am studying competitive cellular uptake
behavior different breast cancer and primary cell lines. In this study, I am going to utilize
the established models with proper modification according to the experiment condition that
will be carried out through confocal microscopy and flow cytometry. I hope this study will
help to understand multidrug inhibition phenomena in a single cell.
Finally, in this dissertation, understanding the experimental and mathematical mod-
eling approaches will help to create broader prospect in study of intracellular signaling
pathways and will able to prevent cancerous diseases in the field of pharmaceuticals.
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